[go: up one dir, main page]

Next Issue
Volume 21, May
Previous Issue
Volume 21, March
 
 
molecules-logo

Journal Browser

Journal Browser

Molecules, Volume 21, Issue 4 (April 2016) – 149 articles

Cover Story (view full-size image): With its epidemic proportion and an attrition rate approaching 100%, Alzheimer’s disease (AD) is an extremely frustrating drug discovery field. Unlike many other major diseases, no medicine has been found to cure or even slow the course of AD. Recently, a small ray of hope has broken through the gloomy outcomes associated with AD: the development of the so-called multitarget drugs. These are single molecules which, acting simultaneously on different pharmacological targets of the disease network, are inherently more adequate to confront AD complex brain pathology. In this issue, Maria Laura Bolognesi, University of Bologna, Italy, and colleagues argue in support of a multitarget drug discovery strategy as a powerful way to develop new, effective, anti-AD drugs. At the same time, they also warn that challenges remain and there is much to learn as we embark on this journey to move them from bench to [...] Read more.
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
  • You may sign up for e-mail alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Order results
Result details
Section
Select all
Export citation of selected articles as:
404 KiB  
Correction
Correction: Popp, J., et al. Biofuels and Their Co-Products as Livestock Feed: Global Economic and Environmental Implications. Molecules 2016, 21, 285.
by József Popp, Mónika Harangi-Rákos, Zoltán Gabnai, Péter Balogh, Gabriella Antal and Attila Bai
Molecules 2016, 21(4), 546; https://doi.org/10.3390/molecules21040546 - 23 Apr 2016
Cited by 1 | Viewed by 3834
Abstract
The authors wish to make the following correction to their paper[1].[...] Full article
(This article belongs to the Section Green Chemistry)
Show Figures

Figure 3

Figure 3
<p>Word biodiesel production, average 2012–2014 [5].</p>
Full article ">
242 KiB  
Review
Selenium in Cattle: A Review
by Youcef Mehdi and Isabelle Dufrasne
Molecules 2016, 21(4), 545; https://doi.org/10.3390/molecules21040545 - 23 Apr 2016
Cited by 195 | Viewed by 14755
Abstract
This review article examines the role of selenium (Se) and the effects of Se supplementation especially in the bovine species. Selenium is an important trace element in cattle. Some of its roles include the participation in the antioxidant defense the cattle farms. The [...] Read more.
This review article examines the role of selenium (Se) and the effects of Se supplementation especially in the bovine species. Selenium is an important trace element in cattle. Some of its roles include the participation in the antioxidant defense the cattle farms. The nutritional requirements of Se in cattle are estimated at 100 μg/kg DM (dry matter) for beef cattle and at 300 μg/kg DM for dairy cows. The rations high in fermentable carbohydrates, nitrates, sulfates, calcium or hydrogen cyanide negatively influence the organism’s use of the selenium contained in the diet. The Se supplementation may reduce the incidence of metritis and ovarian cysts during the postpartum period. The increase in fertility when adding Se is attributed to the reduction of the embryonic death during the first month of gestation. A use of organic Se in feed would provide a better transfer of Se in calves relative to mineral Se supplementation. The addition of Se yeasts in the foodstuffs of cows significantly increases the Se content and the percentage of polyunsaturated fatty acids (PUFA) in milk compared to the addition of sodium selenite. The enzyme 5-iodothyronine deiodinase is a seleno-dependent selenoprotein. It is one of the last proteins to be affected in the event of Se deficiency. This delay in response could explain the fact that several studies did not show the effect of Se supplementation on growth and weight gain of calves. Enrichment of Se in the diet did not significantly affect the slaughter weight and carcass yield of bulls. The impact and results of Se supplementation in cattle depend on physiological stage, Se status of animals, type and content of Se and types of Se administration. Further studies in Se supplementation should investigate the speciation of Se in food and yeasts, as well as understanding their metabolism and absorption. This constitute a path to exploit in order to explain certain different effects of Se. Full article
(This article belongs to the Section Molecular Diversity)
3082 KiB  
Article
Crystallization of Esomeprazole Magnesium Water/Butanol Solvate
by Jenna Skieneh, Bahareh Khalili Najafabadi, Stephen Horne and Sohrab Rohani
Molecules 2016, 21(4), 544; https://doi.org/10.3390/molecules21040544 - 23 Apr 2016
Cited by 12 | Viewed by 10434
Abstract
The molecular structure of esomeprazole magnesium derivative in the solid-state is reported for the first time, along with a simplified crystallization pathway. The structure was determined using the single crystal X-ray diffraction technique to reveal the bonding relationships between esomeprazole heteroatoms and magnesium. [...] Read more.
The molecular structure of esomeprazole magnesium derivative in the solid-state is reported for the first time, along with a simplified crystallization pathway. The structure was determined using the single crystal X-ray diffraction technique to reveal the bonding relationships between esomeprazole heteroatoms and magnesium. The esomeprazole crystallization process was carried out in 1-butanol and water was utilized as anti-solvent. The product proved to be esomeprazole magnesium tetrahydrate with two 1-butanol molecules that crystallized in P63 space group, in a hexagonal unit cell. Complete characterization of a sample after drying was conducted by the use of powder X-ray diffraction (PXRD), 1H-nuclear magnetic resonance (NMR), thermogravimetric analysis (TGA), differential scanning calorimetry (DSC), infrared spectroscopy (IR), and dynamic vapor sorption (DVS). Investigation by 1H-NMR and TGA has shown that the solvent content in the dried sample consists of two water molecules and 0.3 butanol molecules per esomeprazole magnesium molecule. This is different from the single crystal X-ray diffraction results and can be attributed to the loss of some water and 1-butanol molecules stabilized by intermolecular interactions. The title compound, after drying, is a true solvate in terms of water; conversely, 1-butanol fills the voids of the crystal lattice in non-stoichiometric amounts. Full article
(This article belongs to the Special Issue Crystallization of Pharmaceuticals)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>The 5-methoxy and 6-methoxy tautomers of omeprazole.</p>
Full article ">Figure 2
<p>A simplified visualization of (<b>a</b>) a “true” solvate <span class="html-italic">vs.</span> (<b>b</b>) a non-stoichiometric solvate, where the solvent can be one or more types of solvent.</p>
Full article ">Figure 3
<p>Esomeprazole magnesium molecules crystalize in P6<sub>3</sub> spaces group alongside with water and 1-butanol molecules; the molecules of the same color are symmetry equivalent.</p>
Full article ">Figure 4
<p>Two types of coordination around the magnesium centers, hydrogen atoms and non-bonded solvents have been omitted for clarity. Mg: green, S: yellow, O: red, N: blue, C: grey.</p>
Full article ">Figure 5
<p>Strong hydrogen bonding between the molecules in the lattice is shown in blue dotted lines; hydrogen atoms have been omitted for more clarity. Mg: green, S: yellow, O: red, N: blue, C: grey.</p>
Full article ">Figure 6
<p>X-ray powder diffraction of esomeprazole magnesium water/butanol solvate calculated from single crystal structure and esomeprazole magnesium water/butanol solvate after drying under vacuum.</p>
Full article ">Figure 7
<p>TGA of the title sample showing two mass losses. The first loss of 7.6% is desolvation, while the second loss is decomposition of the esomeprazole molecule.</p>
Full article ">Figure 8
<p>The DSC curve of esomeprazole magnesium water/1-butanol solvate. The curve was obtained from 25 to 350 °C at a heating rate of 5 °C/min. An exotherm characteristic of esomeprazole magnesium is seen at 200 °C as well as an endotherm at 175 °C.</p>
Full article ">Figure 9
<p>Esomeprazole magnesium water/1-butanol adsorption of water at increasing humidity followed by desorption at decreasing humidity. The cycle is repeated to give two isotherms.</p>
Full article ">
2036 KiB  
Article
Highly Efficient Reproducible Perovskite Solar Cells Prepared by Low-Temperature Processing
by Hao Hu, Ka Kan Wong, Tom Kollek, Fabian Hanusch, Sebastian Polarz, Pablo Docampo and Lukas Schmidt-Mende
Molecules 2016, 21(4), 542; https://doi.org/10.3390/molecules21040542 - 23 Apr 2016
Cited by 22 | Viewed by 9678
Abstract
In this work, we describe the role of the different layers in perovskite solar cells to achieve reproducible, ~16% efficient perovskite solar cells. We used a planar device architecture with PEDOT:PSS on the bottom, followed by the perovskite layer and an evaporated C [...] Read more.
In this work, we describe the role of the different layers in perovskite solar cells to achieve reproducible, ~16% efficient perovskite solar cells. We used a planar device architecture with PEDOT:PSS on the bottom, followed by the perovskite layer and an evaporated C60 layer before deposition of the top electrode. No high temperature annealing step is needed, which also allows processing on flexible plastic substrates. Only the optimization of all of these layers leads to highly efficient and reproducible results. In this work, we describe the effects of different processing conditions, especially the influence of the C60 top layer on the device performance. Full article
(This article belongs to the Special Issue Perovskite Solar Cells)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>In this figure, a schematic of the used device structure containing all layers is presented. The layer thicknesses are not in scale. The different layer thicknesses are presented in <a href="#sec4dot2-molecules-21-00542" class="html-sec">Section 4.2</a> for optimized solar cell performance.</p>
Full article ">Figure 2
<p>Schematic of the vacuum assisted one-step solution (VAOS) preparation method of the perovskite film.</p>
Full article ">Figure 3
<p>Smooth, uniform, pin-hole free perovskite film (<b>a</b>) top-view; (<b>b</b>) cross-section SEM images.</p>
Full article ">Figure 4
<p>Influence of C<sub>60</sub> layer (<b>a</b>) thickness; and (<b>b</b>) annealing effect on device performance.</p>
Full article ">Figure 5
<p>Effect of lithium fluoride (LiF) layer on Current density -Voltage (J–V) curve.</p>
Full article ">Figure 6
<p>The best solar cell performance without hysteresis behavior (scan rate 0.1 V/s).</p>
Full article ">Figure 7
<p>The statistical distribution of 30 solar cell efficiencies fabricated in three successive processes.</p>
Full article ">
2275 KiB  
Article
3,5,6,7,8,3′,4′-Heptamethoxyflavone, a Citrus Flavonoid, Ameliorates Corticosterone-Induced Depression-like Behavior and Restores Brain-Derived Neurotrophic Factor Expression, Neurogenesis, and Neuroplasticity in the Hippocampus
by Atsushi Sawamoto, Satoshi Okuyama, Kana Yamamoto, Yoshiaki Amakura, Morio Yoshimura, Mitsunari Nakajima and Yoshiko Furukawa
Molecules 2016, 21(4), 541; https://doi.org/10.3390/molecules21040541 - 23 Apr 2016
Cited by 56 | Viewed by 8826
Abstract
We previously reported that the citrus flavonoid 3,5,6,7,8,3′,4′-heptamethoxyflavone (HMF) increased the expression of brain-derived neurotrophic factor (BDNF) in the hippocampus of a transient global ischemia mouse model. Since the BDNF hypothesis of depression postulates that a reduction in BDNF is directly involved in [...] Read more.
We previously reported that the citrus flavonoid 3,5,6,7,8,3′,4′-heptamethoxyflavone (HMF) increased the expression of brain-derived neurotrophic factor (BDNF) in the hippocampus of a transient global ischemia mouse model. Since the BDNF hypothesis of depression postulates that a reduction in BDNF is directly involved in the pathophysiology of depression, we evaluated the anti-depressive effects of HMF in mice with subcutaneously administered corticosterone at a dose of 20 mg/kg/day for 25 days. We demonstrated that the HMF treatment ameliorated (1) corticosterone-induced body weight loss, (2) corticosterone-induced depression-like behavior, and (3) corticosterone-induced reductions in BDNF production in the hippocampus. We also showed that the HMF treatment restored (4) corticosterone-induced reductions in neurogenesis in the dentate gyrus subgranular zone and (5) corticosterone-induced reductions in the expression levels of phosphorylated calcium-calmodulin-dependent protein kinase II and extracellular signal-regulated kinase1/2. These results suggest that HMF exerts its effects as an anti-depressant drug by inducing the expression of BDNF. Full article
Show Figures

Figure 1

Figure 1
<p>Structure of 3,5,6,7,8,3′,4′-heptamethoxyflavone (HMF).</p>
Full article ">Figure 2
<p>Body weight changes on Days 7, 14, and 21. Values are means ± SEM (<span class="html-italic">n</span> = 8). Symbols show significant differences between the following conditions: CON <span class="html-italic">vs.</span> CORT (* <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01) and CORT <span class="html-italic">vs.</span> CORT + HMF (<sup>##</sup> <span class="html-italic">p</span> &lt; 0.01).</p>
Full article ">Figure 3
<p>Effects of HMF on corticosterone-induced behavioral abnormalities in the forced swim test (<b>A</b>) and tail suspension test (<b>B</b>). Values are means ± SEM (<span class="html-italic">n</span> = 7–8). Symbols show significant differences between the following conditions: CON <span class="html-italic">vs.</span> CORT (* <span class="html-italic">p</span> &lt; 0.05), CORT <span class="html-italic">vs.</span> CORT + HMF (<sup>#</sup> <span class="html-italic">p</span> &lt; 0.05), and CORT <span class="html-italic">vs.</span> CORT + FLX (<sup>$</sup> <span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 4
<p>Effects of HMF on the expression of BDNF and GFAP immunoreactivity in the corticosterone-induced depressive mouse hippocampus. (A) Sagittal sections on Day 26 after continuous corticosterone injections were stained with specific antibodies, either anti-BDNF (green; a, b, c, d, e) or anti-GFAP with DAPI staining (red and blue, respectively; f, g, h, i, j). Each signal was merged in k, l, m, n and o, respectively. White squares in the CON group showed a typical astrocyte expressing BDNF, and each high-power magnification picture was shown as e, j, and o. The white and the pink scale bar show 50 µm and 25 µm, respectively. The location of the captured images in the hippocampus and quantification is shown with a square (0.22 mm<sup>2</sup>). (<b>B</b>) A quantitative analysis of BDNF-positive signal densities using ImageJ software. Values are means ± SEM (Day 10; <span class="html-italic">n</span> = 4, Day 17; <span class="html-italic">n</span> = 8, Day 26; <span class="html-italic">n</span> = 8–10). Symbols show significant differences between the following conditions: CON <span class="html-italic">vs.</span> CORT (*** <span class="html-italic">p</span> &lt; 0.001), CORT <span class="html-italic">vs.</span> CORT + HMF (<sup>#</sup> <span class="html-italic">p</span> &lt; 0.05, <sup>##</sup> <span class="html-italic">p</span> &lt; 0.01), and CORT <span class="html-italic">vs.</span> CORT + FLX (<sup>$$</sup> <span class="html-italic">p</span> &lt; 0.01). A quantitative analysis of the average size (<b>C</b>) of GFAP-positive signals on Day 26 using ImageJ software. Values are means ± SEM (<span class="html-italic">n</span> = 8–10). Symbols show significant differences between the following conditions: CON <span class="html-italic">vs.</span> CORT (* <span class="html-italic">p</span> &lt; 0.05), CORT <span class="html-italic">vs.</span> CORT + HMF (<sup>#</sup> <span class="html-italic">p</span> &lt; 0.05), and CORT <span class="html-italic">vs.</span> CORT + FLX (<sup>$</sup> <span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 4 Cont.
<p>Effects of HMF on the expression of BDNF and GFAP immunoreactivity in the corticosterone-induced depressive mouse hippocampus. (A) Sagittal sections on Day 26 after continuous corticosterone injections were stained with specific antibodies, either anti-BDNF (green; a, b, c, d, e) or anti-GFAP with DAPI staining (red and blue, respectively; f, g, h, i, j). Each signal was merged in k, l, m, n and o, respectively. White squares in the CON group showed a typical astrocyte expressing BDNF, and each high-power magnification picture was shown as e, j, and o. The white and the pink scale bar show 50 µm and 25 µm, respectively. The location of the captured images in the hippocampus and quantification is shown with a square (0.22 mm<sup>2</sup>). (<b>B</b>) A quantitative analysis of BDNF-positive signal densities using ImageJ software. Values are means ± SEM (Day 10; <span class="html-italic">n</span> = 4, Day 17; <span class="html-italic">n</span> = 8, Day 26; <span class="html-italic">n</span> = 8–10). Symbols show significant differences between the following conditions: CON <span class="html-italic">vs.</span> CORT (*** <span class="html-italic">p</span> &lt; 0.001), CORT <span class="html-italic">vs.</span> CORT + HMF (<sup>#</sup> <span class="html-italic">p</span> &lt; 0.05, <sup>##</sup> <span class="html-italic">p</span> &lt; 0.01), and CORT <span class="html-italic">vs.</span> CORT + FLX (<sup>$$</sup> <span class="html-italic">p</span> &lt; 0.01). A quantitative analysis of the average size (<b>C</b>) of GFAP-positive signals on Day 26 using ImageJ software. Values are means ± SEM (<span class="html-italic">n</span> = 8–10). Symbols show significant differences between the following conditions: CON <span class="html-italic">vs.</span> CORT (* <span class="html-italic">p</span> &lt; 0.05), CORT <span class="html-italic">vs.</span> CORT + HMF (<sup>#</sup> <span class="html-italic">p</span> &lt; 0.05), and CORT <span class="html-italic">vs.</span> CORT + FLX (<sup>$</sup> <span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 5
<p>Effects of HMF on the expression of doublecortin immunoreactivity in the corticosterone-induced depressive mouse hippocampal dentate gyrus. (<b>A</b>) Sagittal sections on Day 26 after continuous corticosterone injections were stained with specific antibodies, either anti-doublecortin (green; a, b, c, d) or anti-NeuN (red; e, f, g, h). The scale bar shows 50 µm. The location of the captured images in the hippocampus is shown with a square (0.09 mm<sup>2</sup>). (<b>B</b>) A quantitative analysis of doublecortin-positive cell counts was performed manually. Values are means ± SEM (Day 10; <span class="html-italic">n</span> = 4, Day 17; <span class="html-italic">n</span> = 8, Day 26; <span class="html-italic">n</span> = 8–10). Symbols show significant differences between the following conditions: CON <span class="html-italic">vs.</span> CORT (** <span class="html-italic">p</span> &lt; 0.01), CORT <span class="html-italic">vs.</span> CORT + HMF (<sup>###</sup> <span class="html-italic">p</span> &lt; 0.001), and CORT <span class="html-italic">vs.</span> CORT + FLX (<sup>$$</sup> <span class="html-italic">p</span> &lt; 0.01).</p>
Full article ">Figure 6
<p>Effects of HMF on the expression of phosphorylated CaMK II and NeuN immunoreactivity in the corticosterone-induced depressive mouse hippocampus. (<b>A</b>) Sagittal sections on Day 26 after continuous corticosterone injections were stained with specific antibodies, either anti-phospho-CaMK II (green; a, b, c, d) or anti-NeuN (red; e, f, g, h). Each signal was merged in i, j, k and l, respectively. The scale bar shows 200 µm. The location of the captured images in the hippocampus and quantification is shown with a square (1.0 mm<sup>2</sup>). (<b>B</b>) A quantitative analysis of phospho-CaMK II-positive signal density using ImageJ software. Values are means ± SEM (Day 10; <span class="html-italic">n</span> = 4, Day 17; <span class="html-italic">n</span> = 8, Day 26; <span class="html-italic">n</span> = 8–10). Symbols show significant differences between the following conditions: CON <span class="html-italic">vs.</span> CORT (* <span class="html-italic">p</span> &lt; 0.05, *** <span class="html-italic">p</span> &lt; 0.001), CORT <span class="html-italic">vs.</span> CORT + HMF (<sup>#</sup> <span class="html-italic">p</span> &lt; 0.05), and CORT <span class="html-italic">vs.</span> CORT + FLX (<sup>$</sup> <span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 7
<p>A Western blot analysis of the influence of HMF on the expression of phosphorylated ERK in the corticosterone-induced depressive mouse hippocampus. (<b>A</b>) Representative band patterns of p-ERK1/2 and ERK1/2. (<b>B</b>) A quantitative analysis of the p-ERK/ERK ratio using ImageJ software. Values are means ± SEM (Day 10; <span class="html-italic">n</span> = 4, Day 17; <span class="html-italic">n</span> = 5). Symbols show significant differences between the following conditions: CON <span class="html-italic">vs.</span> CORT (** <span class="html-italic">p</span> &lt; 0.01).</p>
Full article ">
4082 KiB  
Review
Bifunctional Phosphorus Dendrimers and Their Properties
by Anne-Marie Caminade and Jean-Pierre Majoral
Molecules 2016, 21(4), 538; https://doi.org/10.3390/molecules21040538 - 23 Apr 2016
Cited by 32 | Viewed by 7851
Abstract
Dendrimers are hyperbranched and monodisperse macromolecules, generally considered as a special class of polymers, but synthesized step-by-step. Most dendrimers have a uniform structure, with a single type of terminal function. However, it is often desirable to have at least two different functional groups. [...] Read more.
Dendrimers are hyperbranched and monodisperse macromolecules, generally considered as a special class of polymers, but synthesized step-by-step. Most dendrimers have a uniform structure, with a single type of terminal function. However, it is often desirable to have at least two different functional groups. This review will discuss the case of bifunctional phosphorus-containing dendrimers, and the consequences for their properties. Besides the terminal functions, dendritic structures may have also a function at the core, or linked off-center to the core, or at the core of dendrons (dendritic wedges). Association of two dendrons having different terminal functions leads to Janus dendrimers (two faces). The internal structure can also possess functional groups on one layer, or linked to one layer, or on several layers. Finally, there are several ways to have two types of terminal functions, besides the case of Janus dendrimers: either each terminal function bears two functions sequentially, or two different functions are linked to each terminal branching point. Examples of each type of structure will be given in this review, as well as practical uses of such sophisticated structures in the fields of fluorescence, catalysis, nanomaterials and biology. Full article
(This article belongs to the Special Issue Functional Dendrimers)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Types of bi-functional dendrimers. (<b>A</b>–<b>C</b>) one function at the core different from the terminal functions; (<b>E</b>–<b>G</b>) functions inside the structure, at one or several layers, different from the terminal functions; <b>D</b>, <b>H</b>, and <b>I</b>: two types of terminal functions.</p>
Full article ">Figure 2
<p>Generation 5 phosphorus dendrimer built from a phthalocyanine core and ended by ammonium groups. <sup>1</sup>H-NMR spectra in water or water/THF mixtures, and variation of the hydrodynamic radius measured by diffusion NMR.</p>
Full article ">Figure 3
<p>Dendrimer having complexes of P,N ligands and PdCl<sub>2</sub> as terminal functions and a triazatriolefinic macrocycle as core. Addition of Pd(dba)<sub>2</sub> induces the formation of Pd nanoparticles.</p>
Full article ">Figure 4
<p>Two dendrimers with a TPA fluorophore as core have been used for imaging the vascular network of a rat olfactory bulb (<b>top</b>), and the blood vessels of a tadpole (<b>bottom</b>).</p>
Full article ">Figure 5
<p>Dendrimer having a pyrene linked off-center to the core and palladium complex of phosphines as terminal groups. Illustration of the interaction of the pyrene at room temperature with the graphene layer covering cobalt nanoparticles. The dendrimers/Co nanoparticles are easily recovered using a magnet, to be reused in a new catalytic cycle. Illustration for the synthesis of felbinac.</p>
Full article ">Figure 6
<p>Examples of dendrimers with an off-center function linked to the core; <b>top</b>: dithiolane for the grafting to gold surfaces; middle: fluorescent maleimide group; <b>bottom</b>: fluorescent julolidine group.</p>
Full article ">Figure 7
<p>Examples of dendrons synthesized for applied purposes. From <b>top to bottom</b>: dendron for catalysis, Et<sub>3</sub>Si group as core for the grafting to silica, vinyl group for the grafting to polystyrene nanoparticles, and two small dendrons with two ethacrynic derivatives as terminal functions, tested as anti-cancer agents.</p>
Full article ">Figure 8
<p>Examples of Janus dendrimers obtained by the association of two dendrons with a diamine.</p>
Full article ">Figure 9
<p>Synthesis of a Janus dendrimer by “click” Staudinger reaction, then functionalization on one side.</p>
Full article ">Figure 10
<p>Examples of functional groups used at one or several layers inside the structure of phosphorhydrazone dendrimers, in replacement of 4-hydroxybenzaldehyde.</p>
Full article ">Figure 11
<p>Examples of dendrimers incorporating viologen units in their structure, and some of their biological properties.</p>
Full article ">Figure 12
<p>Examples of “onion peel” phosphorus dendrimers incorporating viologen units.</p>
Full article ">Figure 13
<p>Synthesis of layered dendrimers using two branched orthogonal monomers of type AB<sub>2</sub> and CD<sub>2</sub>, and structure of branched orthogonal monomers of type AB<sub>5</sub> and CD<sub>5</sub>, usable in the same process.</p>
Full article ">Figure 14
<p>Dendritic structure with two types of functions disposed as patches on the surface of the dendrimer.</p>
Full article ">Figure 15
<p>Isomerization of 1-octen-3-ol carried out with a catalytic amount of ferrocenylphosphino-Ru complex of dendrimer. Switch ON/OFF/ON experiments and influence on the catalytic activity.</p>
Full article ">Figure 16
<p>Examples of bifunctional phenols used for the grafting to P(S)Cl<sub>2</sub> terminal functions of dendrimers.</p>
Full article ">Figure 17
<p>Examples of selective and sequential functionalization of each Cl on P(S)Cl<sub>2</sub> functions, or on a single NH function (<b>bottom</b>).</p>
Full article ">Figure 18
<p>Results of the addition of dimethylphosphonate on terminal aldehydes (<b>left</b>) or imines (<b>right</b>).</p>
Full article ">Scheme 1
<p>Divergent synthesis of phosphorhydrazone dendrimers, from two different cores. Linear representation for (N<sub>3</sub>P<sub>3</sub>)-G<sub>1</sub> that will be used in most of the following figures.</p>
Full article ">
5708 KiB  
Article
Breast Cancer Stem Cell Culture and Enrichment Using Poly(ε-Caprolactone) Scaffolds
by Sònia Palomeras, Marc Rabionet, Inés Ferrer, Ariadna Sarrats, Maria Luisa Garcia-Romeu, Teresa Puig and Joaquim Ciurana
Molecules 2016, 21(4), 537; https://doi.org/10.3390/molecules21040537 - 23 Apr 2016
Cited by 37 | Viewed by 9756
Abstract
The cancer stem cell (CSC) population displays self-renewal capabilities, resistance to conventional therapies, and a tendency to post-treatment recurrence. Increasing knowledge about CSCs’ phenotype and functions is needed to investigate new therapeutic strategies against the CSC population. Here, poly(ε-caprolactone) (PCL), a biocompatible polymer [...] Read more.
The cancer stem cell (CSC) population displays self-renewal capabilities, resistance to conventional therapies, and a tendency to post-treatment recurrence. Increasing knowledge about CSCs’ phenotype and functions is needed to investigate new therapeutic strategies against the CSC population. Here, poly(ε-caprolactone) (PCL), a biocompatible polymer free of toxic dye, has been used to fabricate scaffolds, solid structures suitable for 3D cancer cell culture. It has been reported that scaffold cell culture enhances the CSCs population. A RepRap BCN3D+ printer and 3 mm PCL wire were used to fabricate circular scaffolds. PCL design and fabrication parameters were first determined and then optimized considering several measurable variables of the resulting scaffolds. MCF7 breast carcinoma cell line was used to assess scaffolds adequacy for 3D cell culture. To evaluate CSC enrichment, the Mammosphere Forming Index (MFI) was performed in 2D and 3D MCF7 cultures. Results showed that the 60° scaffolds were more suitable for 3D culture than the 45° and 90° ones. Moreover, 3D culture experiments, in adherent and non-adherent conditions, showed a significant increase in MFI compared to 2D cultures (control). Thus, 3D cell culture with PCL scaffolds could be useful to improve cancer cell culture and enrich the CSCs population. Full article
(This article belongs to the Special Issue Biomaterials and Bioprinting)
Show Figures

Figure 1

Figure 1
<p>Three deposition angle designs fabricated with RepRap Machine. (<b>a</b>) 90° scaffold; (<b>b</b>) 45° scaffold; and (<b>c</b>) 60° scaffold.</p>
Full article ">Figure 2
<p>Cells cultured in 3D conditions with adherent well plates. (<b>a</b>) Inverted optical microscopy images of MCF7 cells seeded on different scaffold designs; (<b>b</b>) cells counted (%) three days after seeding in different deposition angle designed scaffolds. Results are shown as mean ± standard error. *** (<span class="html-italic">p</span> &lt; 0.001) indicates levels of statistically significance.</p>
Full article ">Figure 3
<p>Inverted optical microscopy images of MCF7 cells seeded on scaffolds with adherent and non-adherent wells. (<b>a</b>) 45° and (<b>b</b>) 60° scaffolds in adherent conditions. Cells were attached both at scaffolds and at the surface; (<b>c</b>) 45° and (<b>d</b>) 60° scaffolds in non-adherent conditions. Cells were attached at the scaffolds and also formed suspension aggregates between the PCL filaments.</p>
Full article ">Figure 4
<p>Counted cells (%) in 3D conditions compared to 2D control conditions three days after seeding. Adherent and non-adherent wells were assayed. Results are shown as mean ± standard error. ** (<span class="html-italic">p</span> &lt; 0.01) indicates levels of statistically significance.</p>
Full article ">Figure 5
<p>Counted cells in 45° and 60° scaffolds with previous medium or non-medium addition in the scaffold structure. Results are shown as mean ± standard error.</p>
Full article ">Figure 6
<p>CSCs population analysis. (<b>a</b>) Mammospheres Forming Index (MFI; %) of 2D culture and all 3D conditions. Results are shown as mean ± standard error. (<b>b</b>) Inverted optical microscopy images of a MCF7 mammosphere. ** (<span class="html-italic">p</span> &lt; 0.01) and *** (<span class="html-italic">p</span> &lt; 0.001) indicate levels of statistically significance.</p>
Full article ">Figure 7
<p>Expression of CD44 and CD24 cell surface markers on MCF7 2D cultured cells. (<b>a</b>) Confocal microscopy images of MCF7 cells marked with antibody CD24 and CD44 (<math display="inline"> <semantics> <mrow> <mstyle mathcolor="#538135"> <mtext mathvariant="bold">Green</mtext> </mstyle> </mrow> </semantics> </math>: CD44-FITC; <math display="inline"> <semantics> <mrow> <mstyle mathcolor="red"> <mtext mathvariant="bold">Red</mtext> </mstyle> </mrow> </semantics> </math>: CD24-PE); (<b>b</b>) flow cytometric analysis of CD24 and CD44 surface markers in MCF-7 cells from 2D culture system. Abbreviations: FITC, fluorescein isothiocyanate; PE, phycoerythrin.</p>
Full article ">Figure 8
<p>Scaffolds designs with different deposition angles: (<b>a</b>) 90°; (<b>b</b>) 60°; (<b>c</b>) 45°.</p>
Full article ">Figure 9
<p>Schematic representation of adherent and non-adherent culture.</p>
Full article ">Figure 10
<p>MCF7 cell line in 2D adherent culture.</p>
Full article ">Figure 11
<p>Cell seeding protocol on PCL scaffolds.</p>
Full article ">Figure 12
<p>Mammosphere-forming assay protocol.</p>
Full article ">
146 KiB  
Editorial
Special Issue: Chemoinformatics
by Peter Willett
Molecules 2016, 21(4), 535; https://doi.org/10.3390/molecules21040535 - 22 Apr 2016
Cited by 2 | Viewed by 4396
Abstract
Chemoinformatics techniques were originally developed for the construction and searching of large archives of chemical structures but they were soon applied to problems in drug discovery and are now playing an increasingly important role in many additional areas of chemistry. This Special Issue [...] Read more.
Chemoinformatics techniques were originally developed for the construction and searching of large archives of chemical structures but they were soon applied to problems in drug discovery and are now playing an increasingly important role in many additional areas of chemistry. This Special Issue contains seven original research articles and four review articles that provide an introduction to several aspects of this rapidly developing field. Full article
(This article belongs to the Special Issue Chemoinformatics)
2694 KiB  
Article
Peruvoside, a Cardiac Glycoside, Induces Primitive Myeloid Leukemia Cell Death
by Qian Feng, Wa Seng Leong, Liang Liu and Wai-In Chan
Molecules 2016, 21(4), 534; https://doi.org/10.3390/molecules21040534 - 22 Apr 2016
Cited by 23 | Viewed by 6629
Abstract
Despite the available chemotherapy and treatment, leukemia remains a difficult disease to cure due to frequent relapses after treatment. Among the heterogeneous leukemic cells, a rare population referred as the leukemic stem cell (LSC), is thought to be responsible for relapses and drug [...] Read more.
Despite the available chemotherapy and treatment, leukemia remains a difficult disease to cure due to frequent relapses after treatment. Among the heterogeneous leukemic cells, a rare population referred as the leukemic stem cell (LSC), is thought to be responsible for relapses and drug resistance. Cardiac glycosides (CGs) have been used in treating heart failure despite its toxicity. Recently, increasing evidence has demonstrated its new usage as a potential anti-cancer drug. Ouabain, one of the CGs, specifically targeted CD34+CD38 leukemic stem-like cells, but not the more mature CD34+CD38+ leukemic cells, making this type of compounds a potential treatment for leukemia. In search of other potential anti-leukemia CGs, we found that Peruvoside, a less studied CG, is more effective than Ouabain and Digitoxin at inducing cell death in primitive myeloid leukemia cells without obvious cytotoxicity on normal blood cells. Similar to Ouabain and Digitoxin, Peruvoside also caused cell cycle arrest at G2/M stage. It up-regulates CDKN1A expression and activated the cleavage of Caspase 3, 8 and PARP, resulting in apoptosis. Thus, Peruvoside showed potent anti-leukemia effect, which may serve as a new anti-leukemia agent in the future. Full article
(This article belongs to the Section Natural Products Chemistry)
Show Figures

Figure 1

Figure 1
<p>Peruvoside is more effective in suppressing the growth of human leukemia cells. (<b>a</b>) Structure of Peruvoside, Digitoxin and Ouabain; (<b>b</b>) Dose response of three different cardiac glycosides (CGs) in human leukemia cell line KG1a and K562 at two different time points. MTT assay was used to assess cell viability 24 and 48 h after treatment (<span class="html-italic">n</span> = 3); (<b>c</b>) IC<sub>50</sub> values of different CGs 24 and 48 h after treatment (<span class="html-italic">n</span> = 3).</p>
Full article ">Figure 2
<p>Peruvoside is more effective in inducing apoptosis in human leukemia cells. (<b>a</b>) Flow cytometry analysis of Annexin V (AV) and Propidium Iodide (PI) expression in KG1a and K562 treated with various CGs at different concentrations for 24 h; (<b>b</b>) Graphs show the percentage of early apoptotic cells (AV<sup>+</sup>PI<sup>−</sup>) measured in (<b>a</b>) as well as the fold changes in the percentage of AV<sup>+</sup>PI<sup>−</sup> (treatment/DMSO); (<b>c</b>) Graphs show the fold changes in viable cell numbers (treatment/DMSO). PUV, Peruvoside; DIG, Digitoxin; OUB, Ouabain. <span class="html-italic">n</span> ≥ 3, * <span class="html-italic">p</span> &lt; 0.05; ** <span class="html-italic">p</span> &lt; 0.01, *** <span class="html-italic">p</span> &lt; 0.0001.</p>
Full article ">Figure 2 Cont.
<p>Peruvoside is more effective in inducing apoptosis in human leukemia cells. (<b>a</b>) Flow cytometry analysis of Annexin V (AV) and Propidium Iodide (PI) expression in KG1a and K562 treated with various CGs at different concentrations for 24 h; (<b>b</b>) Graphs show the percentage of early apoptotic cells (AV<sup>+</sup>PI<sup>−</sup>) measured in (<b>a</b>) as well as the fold changes in the percentage of AV<sup>+</sup>PI<sup>−</sup> (treatment/DMSO); (<b>c</b>) Graphs show the fold changes in viable cell numbers (treatment/DMSO). PUV, Peruvoside; DIG, Digitoxin; OUB, Ouabain. <span class="html-italic">n</span> ≥ 3, * <span class="html-italic">p</span> &lt; 0.05; ** <span class="html-italic">p</span> &lt; 0.01, *** <span class="html-italic">p</span> &lt; 0.0001.</p>
Full article ">Figure 3
<p>Peruvoside did not show obvious cytotoxicity on normal human peripheral blood mononuclear cells (PBMCs). (<b>a</b>) Viable cell numbers at different time points after Peruvoside treatment; (<b>b</b>) Flow cytometry analysis of Annexin V and PI expression in PBMCs after being treated with various CGs for 72 h. PUV, Peruvoside; DIG, Digitoxin; OUB, Ouabain.</p>
Full article ">Figure 4
<p>Peruvoside induces cell cycle arrest at G<sub>2</sub>/M, at a level similar to Digitoxin and Ouabain. (<b>a</b>) Cells treated with Peruvoside (100 nM), Digitoxin (400 nM) and Ouabain (100 nM) were stained with PI. Changes in cell cycle distribution of treated cells were analyzed by flow cytometry; (<b>b</b>) Graphs show cell cycle distributions of cells treated with different CGs shown in (<b>a</b>); PUV, Peruvoside; DIG, Digitoxin; OUB, Ouabain. <span class="html-italic">n</span> = 3, *, <span class="html-italic">p</span> &lt; 0.05; **, <span class="html-italic">p</span> &lt; 0.01, ***, <span class="html-italic">p</span> &lt; 0.0001.</p>
Full article ">Figure 5
<p>Peruvoside treatment did not alter the intracellular Reactive Oxygen Species (ROS) level nor the loss of MMR in KG1a and K562 cells. (<b>a</b>) Both cell lines were treated with 100 nM of Peruvoside or 200 nM of Pyocyanin for 2 h before stained with ROS indicator; (<b>b</b>) Both cell lines were treated with a positive control or 100 nM of Peruvoside for 24 h followed by JC-1 staining. Fluorescence signal was measured and analyzed by flow cytometry. PUV: Peruvoside.</p>
Full article ">Figure 6
<p>Up-regulation of cyclin-dependent kinase inhibitor 1A in leukemia cells after Peruvoside treatment. KG1a and K562 cells were treated with different CGs for 24 h. RNA was isolated from each sample and cDNA was synthesized for Real-time PCR analyses with gene specific primers using the SYBR green method. Data was normalized to β-actin expression and the relative quantity of gene expression level was calculated by ΔΔCt method. Changes in expression are presented as fold change relative to DMSO. Dot line indicates DMSO value set as 1. PUV, Peruvoside; DIG, Digitoxin; OUB, Ouabain. <span class="html-italic">n</span> = 3, *, <span class="html-italic">p</span> &lt; 0.05; **, <span class="html-italic">p</span> &lt; 0.01.</p>
Full article ">Figure 7
<p>Peruvoside activates the apoptosis associated Caspase pathway. Western-blotting analysis shows that among other CGs, treatment of Peruvoside (PUV) at 100 nM for 24 h induced the highest level of cleaved Caspase 3 and 8 expression in KG1a. Treatment with Digitoxin (DIG) at 400 nM induced similar level of Caspase 3 and 8 expression as Peruvoside at 100 nM. Peruvoside also induced the expression of cleaved PARP in both K562 and KG1a. PUV, Peruvoside; DIG, Digitoxin; OUB, Ouabain.</p>
Full article ">
390 KiB  
Article
Repellent Activity of the Essential Oil from the Heartwood of Pilgerodendron uviferum (D. Don) Florin against Aegorhinus superciliosus (Coleoptera: Curculionidae)
by Javier Espinoza, Alejandro Urzúa, Jocelyne Tampe, Leonardo Parra and Andrés Quiroz
Molecules 2016, 21(4), 533; https://doi.org/10.3390/molecules21040533 - 22 Apr 2016
Cited by 11 | Viewed by 5640
Abstract
The weevil Aegorhinus superciliosus Guérin (Coleoptera: Curculionidae), which is endemic to Central-Southern Chile and Argentina, is one of the major berry pests in Chile and the most important pest in the La Araucanía Region (38°44′9″S, 72°35′25″W). Due to the poor effectiveness and problems [...] Read more.
The weevil Aegorhinus superciliosus Guérin (Coleoptera: Curculionidae), which is endemic to Central-Southern Chile and Argentina, is one of the major berry pests in Chile and the most important pest in the La Araucanía Region (38°44′9″S, 72°35′25″W). Due to the poor effectiveness and problems surrounding the implementation of the traditional control methods using organophosphate and carbamate insecticides, new strategies for controlling this pest are needed. In this communication, we evaluated the behavioral responses of male and female A. superciliosus to volatile compounds released from the essential oil (EO) obtained from the heartwood of Pilgerodendron uviferum (D. Don) Florin using olfactometric bioassays. The composition of the EO was analyzed using gas chromatography (GC) and gas chromatography/mass spectrometry (GC/MS). According to these analyses, δ-cadinol (24.16%), cubenol (22.64%), 15-copaenol (15.46%) and δ-cadinene (10.81%) were the principal components of the EO. The Pilgerodendron uviferum EO, which is almost exclusively composed of sesquiterpenes (99.5%), exhibited a repellent effect against A. superciliosus adults, regardless of the sex or concentration used (56.6 mg/cm3 and 1.58 × 10−2 mg/cm3). The EO has low volatility and greater persistence than the EOs composed of monoterpenes and is considered a good model in the search for raspberry weevil repellents. Full article
(This article belongs to the Collection Bioactive Compounds)
Show Figures

Figure 1

Figure 1
<p>Average time spent (min ± SE) by <span class="html-italic">A. superciliosus</span> in the olfactometer arms containing pure EO and diluted <span class="html-italic">P. uviferum</span> heartwood EO (2 µL and 50 µL of 10 mg/L EO, <span class="html-italic">i.e.</span>, 56.6 mg/cm<sup>3</sup> and 1.58 × 10<sup>−2</sup> mg/cm<sup>3</sup>, respectively). Control: purified air, DZ: decision zone. The lines on the bars indicate the standard error. Different letters indicate significant differences based on the non-parametric Friedman test followed by the Conover-Inman test (<span class="html-italic">p</span> ≤ 0.05) N = 24.</p>
Full article ">
4856 KiB  
Article
Identification of Subnanometric Ag Species, Their Interaction with Supports and Role in Catalytic CO Oxidation
by Yulia Kotolevich, Ekaterina Kolobova, Evgeniy Khramov, Jesús Efren Cabrera Ortega, Mario H. Farías, Yan Zubavichus, Rodolfo Zanella, Josué D. Mota-Morales, Alexey Pestryakov, Nina Bogdanchikova and Vicente Cortés Corberán
Molecules 2016, 21(4), 532; https://doi.org/10.3390/molecules21040532 - 22 Apr 2016
Cited by 13 | Viewed by 5426
Abstract
The nature and size of the real active species of nanoparticulated metal supported catalysts is still an unresolved question. The technique of choice to measure particle sizes at the nanoscale, HRTEM, has a practical limit of 1 nm. This work is aimed to [...] Read more.
The nature and size of the real active species of nanoparticulated metal supported catalysts is still an unresolved question. The technique of choice to measure particle sizes at the nanoscale, HRTEM, has a practical limit of 1 nm. This work is aimed to identify the catalytic role of subnanometer species and methods to detect and characterize them. In this frame, we investigated the sensitivity to redox pretreatments of Ag/Fe/TiO2, Ag/Mg/TiO2 and Ag/Ce/TiO2 catalysts in CO oxidation. The joint application of HRTEM, SR-XRD, DRS, XPS, EXAFS and XANES methods indicated that most of the silver in all samples is in the form of Ag species with size <1 nm. The differences in catalytic properties and sensitivity to pretreatments, observed for the studied Ag catalysts, could not be explained taking into account only the Ag particles whose size distribution is measured by HRTEM, but may be explained by the presence of the subnanometer Ag species, undetectable by HRTEM, and their interaction with supports. This result highlights their role as active species and the need to take them into account to understand integrally the catalysis by supported nanometals. Full article
(This article belongs to the Special Issue Coinage Metal (Copper, Silver, and Gold) Catalysis)
Show Figures

Figure 1

Figure 1
<p>CO conversion <span class="html-italic">vs.</span> temperature on Ag catalysts on TiO<sub>2</sub> support modified with Ce (<b>a</b>); Fe (<b>b</b>) or Mg (<b>c</b>).</p>
Full article ">Figure 2
<p>Particle size distribution of Ag catalysts supported on Fe/TiO<sub>2</sub> (<b>a</b>); Mg/TiO<sub>2</sub> (<b>c</b>) and Ce/TiO<sub>2</sub> (<b>d</b>) treated in H<sub>2</sub> at 300 °C for 1 h. Microphotographs of catalyst Ag/Fe/TiO<sub>2</sub> (<b>b</b>) and supports: Fe/TiO<sub>2</sub> (<b>e</b>); Mg/TiO<sub>2</sub> (<b>f</b>); Ce/TiO<sub>2</sub> (<b>g</b>) and TiO<sub>2</sub> (<b>h</b>).</p>
Full article ">Figure 3
<p>The SR-XRD patterns for the supports (<b>a</b>) and catalysts treated in H<sub>2</sub> flow at 300 °C for 1 h (<b>b</b>).</p>
Full article ">Figure 4
<p>Low-magnification HRTEM micrograph and corresponding elemental maps in false colors for Ag and Ce extracted from the EDS data cube for Ag/Ce/TiO<sub>2</sub> sample treated in H<sub>2</sub> flow at 300 °C for 1 h.</p>
Full article ">Figure 5
<p>DRS of the supports based on TiO<sub>2</sub>, modified with Ce (<b>a</b>); Mg (<b>b</b>) or Fe (<b>c</b>) oxides and their corresponding catalysts before (as-prepared) and after reduction in H<sub>2</sub> under 300 °C for 1 h.</p>
Full article ">Figure 5 Cont.
<p>DRS of the supports based on TiO<sub>2</sub>, modified with Ce (<b>a</b>); Mg (<b>b</b>) or Fe (<b>c</b>) oxides and their corresponding catalysts before (as-prepared) and after reduction in H<sub>2</sub> under 300 °C for 1 h.</p>
Full article ">Figure 6
<p>XPS of lines Ag 3d5/2 for Ag catalysts supported on Mg/TiO<sub>2</sub> (<b>a</b>); Fe/TiO<sub>2</sub> (<b>b</b>) and Ce/TiO<sub>2</sub> (<b>c</b>) after reduction in H2 at 300 °C for 1 h.</p>
Full article ">Figure 7
<p>Lattice constants of anatase (<b>a</b>,<b>b</b>) and rutile (<b>c</b>,<b>d</b>) calculated on the basis of EXAFS data for the studied supports.</p>
Full article ">Figure 8
<p>XPS lines of O1s (<b>a</b>,<b>b</b>) and C1s (<b>c</b>,<b>d</b>) for supports (<b>a</b>,<b>c</b>) and Ag catalysts after reduction in H<sub>2</sub> at 300 °C for 1 h (<b>b</b>,<b>d</b>).</p>
Full article ">Figure 9
<p>XANES (<b>a</b>) and EXAFS (<b>b</b>) spectra of catalysts treated in H<sub>2</sub> flow at 300 °C for 1 h.</p>
Full article ">
1187 KiB  
Article
Volatile Organic Compounds Emissions from Luculia pinceana Flower and Its Changes at Different Stages of Flower Development
by Yuying Li, Hong Ma, Youming Wan, Taiqiang Li, Xiuxian Liu, Zhenghai Sun and Zhenghong Li
Molecules 2016, 21(4), 531; https://doi.org/10.3390/molecules21040531 - 22 Apr 2016
Cited by 31 | Viewed by 8261
Abstract
Luculia plants are famed ornamental plants with sweetly fragrant flowers, of which L. pinceana Hooker, found primarily in Yunnan Province, China, has the widest distribution. Solid phase microextraction-gas chromatography-mass spectrometry (SPME-GC-MS) was employed to identify the volatile organic compounds (VOCs) emitted from different [...] Read more.
Luculia plants are famed ornamental plants with sweetly fragrant flowers, of which L. pinceana Hooker, found primarily in Yunnan Province, China, has the widest distribution. Solid phase microextraction-gas chromatography-mass spectrometry (SPME-GC-MS) was employed to identify the volatile organic compounds (VOCs) emitted from different flower development stages of L. pinceana for the evaluation of floral volatile polymorphism. Peak areas were normalized as percentages and used to determine the relative amounts of the volatiles. The results showed that a total of 39 compounds were identified at four different stages of L. pinceana flower development, including 26 at the bud stage, 26 at the initial-flowering stage, 32 at the full-flowering stage, and 32 at the end-flowering stage. The most abundant compound was paeonol (51%–83%) followed by (E,E)-α-farnesene, cyclosativene, and δ-cadinene. All these volatile compounds create the unique fragrance of L. pinceana flower. Floral scent emission offered tendency of ascending first and descending in succession, meeting its peak level at the initial-flowering stage. The richest diversity of floral volatile was detected at the third and later periods of flower development. Principal component analysis (PCA) indicated that the composition and its relative content of floral scent differed throughout the whole flower development. The result has important implications for future floral fragrance breeding of Luculia. L. pinceana would be adequate for a beneficial houseplant and has a promising prospect for development as essential oil besides for a fragrant ornamental owing to the main compounds of floral scent with many medicinal properties. Full article
(This article belongs to the Section Natural Products Chemistry)
Show Figures

Figure 1

Figure 1
<p>The morphological characteristics of <span class="html-italic">L. pinceana</span> flower in four different stages. (<b>I</b>) bud stage; (<b>II</b>) initial-flowering stage; (<b>III</b>) full-flowering stage; and (<b>IV</b>) end-flowering stage.</p>
Full article ">Figure 2
<p>Total ionic chromatogram of volatile components emitted from flowers of <span class="html-italic">L. pinceana</span> in different stages. (<b>I</b>) bud stage; (<b>II</b>) initial-flowering stage; (<b>III</b>) full-flowering stage; and (<b>IV</b>) end-flowering stage.</p>
Full article ">Figure 3
<p>Principal component plot (PC1 <span class="html-italic">vs.</span> PC2 plots (<b>a</b>) and PC1 <span class="html-italic">vs.</span> PC3 plots (<b>b</b>)) for <span class="html-italic">L. pinceana</span> at different stages of growth, showing correlations with volatiles (numbers correspond to those in <a href="#molecules-21-00531-t001" class="html-table">Table 1</a>). (<b>I</b>) bud stage; (<b>II</b>) initial-flowering stage; (<b>III</b>) full-flowering stage; and (<b>IV</b>) end-flowering stage.</p>
Full article ">
2560 KiB  
Article
Enantioselective Separation of 4,8-DHT and Phytotoxicity of the Enantiomers on Various Plant Species
by Li Yang, Xiao-Yan Ma, Xiao Ruan, De-An Jiang, Cun-De Pan and Qiang Wang
Molecules 2016, 21(4), 528; https://doi.org/10.3390/molecules21040528 - 22 Apr 2016
Cited by 7 | Viewed by 5092
Abstract
As a candidate for bioherbicide, 4,8-dihydroxy-1-tetralone (4,8-DHT) was isolated from Caryospora callicarpa epicarp and its two enantiomers, S-(+)-isosclerone and R-(−)-regiolone, were separated by chiral high-performance liquid chromatography (HPLC) on a Chiralcel OD column with chiral stationary phase (CSP)-coated cellulose-tris(3,5-dimethylphenylcarbamate). Then, the [...] Read more.
As a candidate for bioherbicide, 4,8-dihydroxy-1-tetralone (4,8-DHT) was isolated from Caryospora callicarpa epicarp and its two enantiomers, S-(+)-isosclerone and R-(−)-regiolone, were separated by chiral high-performance liquid chromatography (HPLC) on a Chiralcel OD column with chiral stationary phase (CSP)-coated cellulose-tris(3,5-dimethylphenylcarbamate). Then, the phytotoxicity of 4,8-DHT and its enantiomers toward the seeds germination and seedling growth of the five tested plant species, including lettuce (Latuca sativa), radish (Raphanus sativus), cucumber (Cucumis sativus), onion (Allium cepa), and wheat (Triticum aestivum), were investigated and the results indicated a hormesis at low concentration of 4,8-DHT and its enantiomers, but a retardant effect at high concentration. Between the two enantiomers of 4,8-DHT, the S-(+)-isosclerone was more toxic to seeds germination and seedling growth of the five tested plant species than the R-(−)-regiolone, and also the phytotoxicity of S-(+)-isosclerone varied with different plants. For example, S-(+)-isosclerone was the most active to seedling growth of lettuce, indicating that S-(+)-isosclerone had specific effects on different organisms. Thus, all of the chirality and concentration of 4,8-DHT, as well as the affected plant species, need to be taken into consideration in the development and utilization of 4,8-DHT. Full article
Show Figures

Figure 1

Figure 1
<p>The elution order of 4,8-DHT enantiomers. <span class="html-italic">Conditions</span>: mobile phase, <span class="html-italic">n</span>-hexane/iso-propanol/AA (95:5:0.1, <span class="html-italic">v</span>/<span class="html-italic">v</span>/%); flow rate, 0.8 mL·min<sup>−1</sup>; column temperature, 20 °C.</p>
Full article ">Figure 2
<p>Effect of rac-4,8-DHT, <span class="html-italic">S</span>-(+)-isosclerone, and <span class="html-italic">R</span>-(−)-regiolone at different concentrations on radicle length (<b>A</b>); plumule length (<b>B</b>); and fresh weight (<b>C</b>) in lettuce. a denotes a significant difference between control and treatments (<span class="html-italic">p</span> &lt; 0.05); b denotes significant difference among rac-4,8-DHT, <span class="html-italic">S</span>-(+)-isosclerone, and <span class="html-italic">R</span>-(−)-regiolone (<span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 3
<p>Effect of rac-4,8-DHT, <span class="html-italic">S</span>-(+)-isosclerone, and <span class="html-italic">R</span>-(−)-regiolone at different concentrations on radicle length (<b>A</b>); plumule length (<b>B</b>); and fresh weight (<b>C</b>) in cucumber. a denotes a significant difference between control and treatments (<span class="html-italic">p</span> &lt; 0.05); b denotes a significant difference among rac-4,8-DHT, <span class="html-italic">S</span>-(+)-isosclerone, and <span class="html-italic">R</span>-(−)-regiolone (<span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 4
<p>Effect of rac-4,8-DHT, <span class="html-italic">S</span>-(+)-isosclerone, and <span class="html-italic">R</span>-(−)-regiolone at different concentrations on radicle length (<b>A</b>); plumule length (<b>B</b>); and fresh weight (<b>C</b>) in radish. a denotes a significant difference between control and treatments (<span class="html-italic">p</span> &lt; 0.05); b denotes a significant difference among rac-4,8-DHT, <span class="html-italic">S</span>-(+)-isosclerone and <span class="html-italic">R</span>-(−)-regiolone (<span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 5
<p>Effect of rac-4,8-DHT, <span class="html-italic">S</span>-(+)-isosclerone, and <span class="html-italic">R</span>-(−)-regiolone at different concentrations on radicle length (<b>A</b>); plumule length (<b>B</b>); and fresh weight (<b>C</b>) in onion. a denotes significant difference between control and treatments (<span class="html-italic">p</span> &lt; 0.05); b denotes significant difference among rac-4,8-DHT, <span class="html-italic">S</span>-(+)-isosclerone and <span class="html-italic">R</span>-(−)-regiolone (<span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 6
<p>Effect of rac-4,8-DHT, <span class="html-italic">S</span>-(+)-isosclerone, and <span class="html-italic">R</span>-(−)-regiolone at different concentrations on radicle length (<b>A</b>); plumule length (<b>B</b>); and fresh weight (<b>C</b>) in wheat. a denotes a significant difference between control and treatments (<span class="html-italic">p</span> &lt; 0.05); b denotes a significant difference among rac-4,8-DHT, <span class="html-italic">S</span>-(+)-isosclerone and <span class="html-italic">R</span>-(−)-regiolone (<span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">
7781 KiB  
Article
The Effects of Topical Application of Polycal (a 2:98 (g/g) Mixture of Polycan and Calcium Gluconate) on Experimental Periodontitis and Alveolar Bone Loss in Rats
by Sang-In Park, Su-Jin Kang, Chang-Hyun Han, Joo-Wan Kim, Chang-Hyun Song, Sang-Nam Lee, Sae-Kwang Ku and Young-Joon Lee
Molecules 2016, 21(4), 527; https://doi.org/10.3390/molecules21040527 - 22 Apr 2016
Cited by 14 | Viewed by 5640
Abstract
The aim of this study was to observe whether Polycal has inhibitory activity on ligation-induced experimental periodontitis and related alveolar bone loss in rats following topical application to the gingival regions. One day after the ligation placements, Polycal (50, 25, and 12.5 mg/mL [...] Read more.
The aim of this study was to observe whether Polycal has inhibitory activity on ligation-induced experimental periodontitis and related alveolar bone loss in rats following topical application to the gingival regions. One day after the ligation placements, Polycal (50, 25, and 12.5 mg/mL solutions at 200 μL/rat) was topically applied to the ligated gingival regions daily for 10 days. Changes in bodyweight, alveolar bone loss index, and total number of buccal gingival aerobic bacterial cells were monitored, and the anti-inflammatory effects were investigated via myeloperoxidase activity and levels of the pro-inflammatory cytokines IL-1β and TNF-α. The activities of inducible nitric oxide synthase (iNOS) and lipid peroxidation (MDA) were also evaluated. Bacterial proliferation, periodontitis, and alveolar bone loss induced by ligature placements were significantly inhibited after 10 days of continuous topical application of Polycal. These results indicate that topical application of Polycal has a significant inhibitory effect on periodontitis and related alveolar bone loss in rats mediated by antibacterial, anti-inflammatory, and anti-oxidative activities. Full article
(This article belongs to the Section Medicinal Chemistry)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Body weights changes in Intact or EPD Rats. Note that significant (<span class="html-italic">p</span> &lt; 0.01 or <span class="html-italic">p</span> &lt; 0.05) decreases of body weights were detected in EPD control from four days after ligature placement (from Day 3 after initiation of administration) as compared with Intact control (dot arrow). However, the body weights of all three concentrations of Polycal topical applied rats were markedly increased as compared with EPD control from nine days after start of administration (arrow). In contrary, significant (<span class="html-italic">p</span> &lt; 0.01 or <span class="html-italic">p</span> &lt; 0.05) decreases of body weights were detected in IND 5 mg/kg orally administered rats from six days after initiation of administration as compared with EPD control (arrowhead), in this experiment. Values are expressed mean ± S.D. of eight rats. EPD = Experimental periodontal diseases induced by ligature placement around the cervix of upper left incisor teeth; Polycal = Polycan and calcium gluconate 2:98 (g/g) mixture, which was topically applied to ligated gingival regions, once a day for 10 days (200 μL/rats); IND = Indomethacin, which was orally administered at 5 mg/kg dose level, once a day for 10 days; The day −1 means the day of ligature placement. All rats were overnight fasted before ligature placement and sacrifice, respectively (†). <sup>a</sup> <span class="html-italic">p &lt;</span> 0.01 and <sup>b</sup> <span class="html-italic">p &lt;</span> 0.05 as compared with Intact control; <sup>c</sup> <span class="html-italic">p &lt;</span> 0.01 and <sup>d</sup> <span class="html-italic">p &lt;</span> 0.05 as compared with EPD control.</p>
Full article ">Figure 2
<p>Alveolar Bone Loss Scores in Intact or EPD Rats. Note that significant increases of exposed teeth roots areas and the alveolar bone loss scores were detected in EPD control as compared with Intact control. However, significant decreases of alveolar bone loss scores were detected in IND 5 mg/kg orally administrated rats and also in all three different concentrations of Polycal topically applied rats as compared with EPD control, respectively. Especially, all three different concentrations of Polycal topical applied rats showed decreases of bone loss scores as compared with EPD control rats. Values are expressed mean ± S.D. of eight rats, mm. EPD = experimental periodontal diseases induced by ligature placement around the cervix of upper left incisor teeth; Polycal = Polycan and calcium gluconate 2:98 (g/g) mixture, which was topically applied to ligated gingival regions, once a day for 10 days (200 μL/rats); IND = Indomethacin, which was orally administered at 5 mg/kg dose level, once a day for 10 days. <sup>a</sup> <span class="html-italic">p &lt;</span> 0.01 as compared with Intact control; <sup>b</sup> <span class="html-italic">p &lt;</span> 0.01 as compared with EPD control.</p>
Full article ">Figure 3
<p>Gingival viable bacteria counts in Intact or EPD Rats. Note that significant increases of gingival viable bacteria numbers were detected in EPD control as compared with Intact control. However, significant decreases of viable bacteria numbers were detected in all three different concentrations of Polycal topical applied rats as compared with EPD control, respectively. Anyway, no meaningful changes on the viable bacteria numbers were demonstrated in IND 5 mg/kg oral administered rats as compared with EPD control, in this result. Values are expressed mean ± S.D. of eight rats, Log CFU × 10<sup>5</sup>/g tissue. EPD = experimental periodontal diseases induced by ligature placement around the cervix of upper left incisor teeth; Polycal = Polycan and calcium gluconate 2:98 (g/g) mixture, which was topically applied to ligated gingival regions, once a day for 10 days (200 μL/rats); IND = Indomethacin, which was orally administered at 5 mg/kg dose level, once a day for 10 days. <sup>a</sup> <span class="html-italic">p &lt;</span> 0.01 as compared with Intact control; <sup>b</sup> <span class="html-italic">p &lt;</span> 0.01 as compared with EPD control.</p>
Full article ">Figure 4
<p>Gingival MPO activities in Intact or EPD rats. Values are expressed mean ± S.D. of eight rats, U/mg tissue. EPD = experimental periodontal diseases induced by ligature placement around the cervix of upper left incisor teeth; Polycal = Polycan and calcium gluconate 2:98 (g/g) mixture, which was topically applied to ligated gingival regions, once a day for 10 days (200 μL/rats); IND = Indomethacin, which was orally administered at 5 mg/kg dose level, once a day for 10 days. MPO = Myeloperoxidase. <sup>a</sup> <span class="html-italic">p &lt;</span> 0.01 and <sup>b</sup> <span class="html-italic">p &lt;</span> 0.05 as compared with Intact control; <sup>c</sup> <span class="html-italic">p &lt;</span> 0.01 as compared with EPD control.</p>
Full article ">Figure 5
<p>Gingival IL-1β levels in Intact or EPD rats. Values are expressed mean ± S.D. of eight rats, pg/mL. EPD = experimental periodontal diseases induced by ligature placement around the cervix of upper left incisor teeth; Polycal = Polycan and calcium gluconate 2:98 (g/g) mixture, which was topically applied to ligated gingival regions, once a day for 10 days (200 μL/rats); IND = Indomethacin, which was orally administered at 5 mg/kg dose level, once a day for 10 days. IL = Interleukin. <sup>a</sup> <span class="html-italic">p &lt;</span> 0.01 as compared with Intact control; <sup>b</sup> <span class="html-italic">p &lt;</span> 0.01 as compared with EPD control.</p>
Full article ">Figure 6
<p>Gingival TNF-α Levels in Intact or EPD Rats. Values are expressed mean ± S.D. of eight rats, pg/mL. EPD = experimental periodontal diseases induced by ligature placement around the cervix of upper left incisor teeth; Polycal = Polycan and calcium gluconate 2:98 (g/g) mixture, which was topically applied to ligated gingival regions, once a day for 10 days (200 μL/rats). IND = Indomethacin, which was orally administered at 5 mg/kg dose level, once a day for 10 days; TNF = Tumor necrosis factor. <sup>a</sup> <span class="html-italic">p &lt;</span> 0.01 as compared with Intact control; <sup>b</sup> <span class="html-italic">p &lt;</span> 0.01 as compared with EPD control.</p>
Full article ">Figure 7
<p>Gingival MDA levels in Intact or EPD Rats. Values are expressed mean ± S.D. of eight rats, μM/mg tissue. EPD = experimental periodontal diseases induced by ligature placement around the cervix of upper left incisor teeth; Polycal = Polycan and calcium gluconate 2:98 (g/g) mixture, which was topically applied to ligated gingival regions, once a day for 10 days (200 μL/rats). IND = Indomethacin, which was orally administered at 5 mg/kg dose level, once a day for 10 days; MDA = Malondialdehyde. <sup>a</sup> <span class="html-italic">p &lt;</span> 0.01 as compared with Intact control; <sup>b</sup> <span class="html-italic">p &lt;</span> 0.01 as compared with EPD control.</p>
Full article ">Figure 8
<p>Gingival iNOS activities in Intact or EPD rats. Values are expressed mean ± S.D. of eight rats, fM/mg tissue/min. EPD = experimental periodontal diseases induced by ligature placement around the cervix of upper left incisor teeth; Polycal = Polycan and calcium gluconate 2:98 (g/g) mixture, which was topically applied to ligated gingival regions, once a day for 10 days (200 μL/rats); IND = Indomethacin, which was orally administered at 5 mg/kg dose level, once a day for 10 days; iNOS = Inducible nitric oxide synthase. <sup>a</sup> <span class="html-italic">p &lt;</span> 0.01 as compared with Intact control; <sup>b</sup> <span class="html-italic">p &lt;</span> 0.01 as compared with EPD control.</p>
Full article ">Figure 9
<p>Representative histological images of gingival tissues between upper incisor teeth, taken from Intact or EPD rats around upper left incisor teeth: (<b>a</b>) Intact control (Normal control, non-ligated and distilled water topically applied rats); (<b>b</b>) EPD control (Ligated EPD induced and distilled water topically applied rats); (<b>c</b>) IND (Ligated EPD induced and indomethacin 5 mg/kg orally administered rats); (<b>d</b>) Polycal-H (Ligated EPD induced and Polycal 50 mg/mL solution topically applied rats); (<b>e</b>) Polycal-M (Ligated EPD induced and Polycal 25 mg/mL solution topically applied rats); and (<b>f</b>) Polycal-L (Ligated EPD induced and Polycal 12.5 mg/mL solution topically applied rats). All H &amp; E stain. Scale bars = 120 µm.</p>
Full article ">Figure 9 Cont.
<p>Representative histological images of gingival tissues between upper incisor teeth, taken from Intact or EPD rats around upper left incisor teeth: (<b>a</b>) Intact control (Normal control, non-ligated and distilled water topically applied rats); (<b>b</b>) EPD control (Ligated EPD induced and distilled water topically applied rats); (<b>c</b>) IND (Ligated EPD induced and indomethacin 5 mg/kg orally administered rats); (<b>d</b>) Polycal-H (Ligated EPD induced and Polycal 50 mg/mL solution topically applied rats); (<b>e</b>) Polycal-M (Ligated EPD induced and Polycal 25 mg/mL solution topically applied rats); and (<b>f</b>) Polycal-L (Ligated EPD induced and Polycal 12.5 mg/mL solution topically applied rats). All H &amp; E stain. Scale bars = 120 µm.</p>
Full article ">Figure 10
<p>Representative histological images of alveolar bone areas between the upper incisor teeth, taken from Intact or EPD rats around upper left incisor teeth: (<b>a</b>) Intact control (Normal control, non-ligated and distilled water topically applied rats); (<b>b</b>) EPD control (Ligated EPD induced and distilled water topically applied rats); (<b>c</b>) IND (Ligated EPD induced and indomethacin 5 mg/kg orally administered rats); (<b>d</b>) Polycal-H (Ligated EPD induced and Polycal 50 mg/mL solution topically applied rats); (<b>e</b>) Polycal-M (Ligated EPD induced and Polycal 25 mg/mL solution topically applied rats); and (<b>f</b>) Polycal-L (Ligated EPD induced and Polycal 12.5 mg/mL solution topically applied rats). All H &amp; E stain. Scale bars = 120 µm.</p>
Full article ">Figure 10 Cont.
<p>Representative histological images of alveolar bone areas between the upper incisor teeth, taken from Intact or EPD rats around upper left incisor teeth: (<b>a</b>) Intact control (Normal control, non-ligated and distilled water topically applied rats); (<b>b</b>) EPD control (Ligated EPD induced and distilled water topically applied rats); (<b>c</b>) IND (Ligated EPD induced and indomethacin 5 mg/kg orally administered rats); (<b>d</b>) Polycal-H (Ligated EPD induced and Polycal 50 mg/mL solution topically applied rats); (<b>e</b>) Polycal-M (Ligated EPD induced and Polycal 25 mg/mL solution topically applied rats); and (<b>f</b>) Polycal-L (Ligated EPD induced and Polycal 12.5 mg/mL solution topically applied rats). All H &amp; E stain. Scale bars = 120 µm.</p>
Full article ">Figure 11
<p>Histological scores in Intact or EPD rats. Values are expressed mean ± S.D. of eight rats, score (Max = 3). EPD = experimental periodontal diseases induced by ligature placement around the cervix of upper left incisor teeth; Polycal = Polycan and calcium gluconate 2:98 (g/g) mixture, which was topically applied to ligated gingival regions, once a day for 10 days (200 μL/rats); IND = Indomethacin, which was orally administered at 5 mg/kg dose level, once a day for 10 days. <sup>a</sup> <span class="html-italic">p</span> &lt; 0.01 as compared with Intact control; <sup>b</sup> <span class="html-italic">p</span> &lt; 0.01 as compared with EPD control.</p>
Full article ">
2467 KiB  
Article
Glycyrrhetic Acid Ameliorates Dextran Sulfate Sodium-Induced Ulcerative Colitis in Vivo
by Yong-Deok Jeon, Sa-Haeng Kang, Keuk-Soo Bang, Young-Nam Chang, Jong-Hyun Lee and Jong-Sik Jin
Molecules 2016, 21(4), 523; https://doi.org/10.3390/molecules21040523 - 22 Apr 2016
Cited by 28 | Viewed by 6793
Abstract
Glycyrrhizae Radix (GR) is a Korean traditional herb medicine that is widely used in clinical health care. Glycyrrhetic acid (GA) is an aglycone saponin extracted from GR that has anti-inflammatory, anti-cancer, and anti-viral effects. However, the anti-inflammatory effects of GA in colitis have [...] Read more.
Glycyrrhizae Radix (GR) is a Korean traditional herb medicine that is widely used in clinical health care. Glycyrrhetic acid (GA) is an aglycone saponin extracted from GR that has anti-inflammatory, anti-cancer, and anti-viral effects. However, the anti-inflammatory effects of GA in colitis have not been reported. This study investigated the role of GA on ulcerative colitis in a dextran sulfate sodium (DSS)-induced mouse colitis model. DSS-treated mice displayed weight loss and shortened colon length compared with control mice. Mice administered GA showed less weight loss and longer colon length than the DSS-treated group. Interleukin (IL)-6, IL-1β, and tumor necrosis factor-alpha were decreased by GA treatment. GA treatment also reduced DSS-induced microscopic damage to colon tissue. GA regulates the phosphorylation of transcription factors including nuclear factor-kappa B (NF-κB) and IκB alpha, and regulates the expression of cycloxygenase-2 and prostaglandin E2. GA thus showed beneficial effects in a mouse model of colitis, implicating GA might be a useful herb-derived medicine in the treatment of ulcerative colitis. Full article
(This article belongs to the Section Natural Products Chemistry)
Show Figures

Figure 1

Figure 1
<p>Effects of GA on clinical signs in DSS-induced colitis. (<b>A</b>) Body weight was measured at the same time on the experimental days; (<b>B</b>) Disease activity index score in the five study groups. Values represent mean ± S.E.M. (<span class="html-italic">n</span> = 6). Data were analyzed by Student’s <span class="html-italic">t</span>-test (<sup>#</sup> <span class="html-italic">p</span> &lt; 0.05 <span class="html-italic">vs.</span> control and * <span class="html-italic">p</span> &lt; 0.05 <span class="html-italic">vs.</span> DSS alone).</p>
Full article ">Figure 2
<p>Effects of GA on DSS-induced colon shortening. (<b>A</b>) Average colon length in cm measured after 10 days at the time of sacrifice; (<b>B</b>) Representative colons of each group. Values represent mean ± S.E.M. (<span class="html-italic">n</span> = 6). Data were analyzed by Student’s <span class="html-italic">t</span>-test (<sup>#</sup> <span class="html-italic">p</span> &lt; 0.05 <span class="html-italic">vs.</span> control and * <span class="html-italic">p</span> &lt; 0.05 <span class="html-italic">vs.</span> DSS alone).</p>
Full article ">Figure 3
<p>Effects of inflammatory cytokines levels in DSS-induced UC. (<b>A</b>) IL-6 production in mouse serum at day 10; (<b>B</b>) TNF-α production in mouse serum at day 10; (<b>C</b>) IL-1β production in mouse serum at day 10. Values represent mean ± S.E.M. (<span class="html-italic">n</span> = 6). Data were analyzed by Student’s <span class="html-italic">t</span>-test (<sup>#</sup> <span class="html-italic">p</span> &lt; 0.05 <span class="html-italic">vs.</span> control and * <span class="html-italic">p</span> &lt; 0.05 <span class="html-italic">vs.</span> DSS alone).</p>
Full article ">Figure 4
<p>Effects of GA on transcription factors in DSS-induced UC. (<b>A</b>) Phosphorylation of IκBα and phosphorylation of NF-κB were assayed by Western blot; (<b>B</b>) Relative ratio of phospho-IκBα and NF-κB p65 calculated using an image analyzer. Values represent mean ± S.E.M. (<span class="html-italic">n</span> = 6). Data were analyzed by Student’s <span class="html-italic">t</span>-test (<sup>#</sup> <span class="html-italic">p</span> &lt; 0.05 <span class="html-italic">vs.</span> control and * <span class="html-italic">p</span> &lt; 0.05 <span class="html-italic">vs.</span> DSS alone).</p>
Full article ">Figure 5
<p>Effects of GA on epithelial injury in DSS-induced UC. (<b>A</b>) Paraffin sections of colonic tissue were stained with hematoxylin &amp; eosin, and then observed by microscope (10× and 40×); (<b>B</b>) Microscopic scores. Values represent mean ± S.E.M. (<span class="html-italic">n</span> = 6). Data were analyzed by Student’s <span class="html-italic">t</span>-test (<sup>#</sup> <span class="html-italic">p</span> &lt; 0.05 <span class="html-italic">vs.</span> control and * <span class="html-italic">p</span> &lt; 0.05 <span class="html-italic">vs.</span> DSS alone).</p>
Full article ">Figure 6
<p>Effects of GA on COX-2 and PGE<sub>2</sub> expression in DSS-induced UC. COX-2 levels were determined by western blot analysis, and PGE<sub>2</sub> levels using PGE<sub>2</sub> assay kits. (<b>A</b>) Western blot analysis was used to determine COX-2 levels in colonic tissues. Data shown are representative of three independent experiments; (<b>B</b>) COX-2/GAPDH ratios were determined by densitometry; (<b>C</b>) PGE<sub>2</sub> production in colonic tissues. Values represent mean ± S.E.M. (<span class="html-italic">n</span> = 6). Data were analyzed by Student’s <span class="html-italic">t</span>-test (<sup>#</sup> <span class="html-italic">p</span> &lt; 0.05 <span class="html-italic">vs.</span> control and * <span class="html-italic">p</span> &lt; 0.05 <span class="html-italic">vs.</span> DSS alone).</p>
Full article ">
2120 KiB  
Article
Effect of Food Emulsifiers on Aroma Release
by Jia-Jia Li, Man Dong, Yan-Long Liu, Lu-Lu Zhang, Yan Zhang, Zi-Yu Yang, Jing-Nan Ren, Si-Yi Pan and Gang Fan
Molecules 2016, 21(4), 511; https://doi.org/10.3390/molecules21040511 - 22 Apr 2016
Cited by 12 | Viewed by 8946
Abstract
This study aimed to determine the influence of different emulsifiers or xanthan-emulsifier systems on the release of aroma compounds. Solid-phase microextraction (SPME) and GC-MS were used to study the effects of varying concentrations of xanthan gum, sucrose fatty acid ester, Tween 80 and [...] Read more.
This study aimed to determine the influence of different emulsifiers or xanthan-emulsifier systems on the release of aroma compounds. Solid-phase microextraction (SPME) and GC-MS were used to study the effects of varying concentrations of xanthan gum, sucrose fatty acid ester, Tween 80 and soybean lecithin on the release of seven aroma compounds. The effects of the emulsifier systems supplemented with xanthan gum on aroma release were also studied in the same way. The results showed varying degrees of influence of sucrose fatty acid ester, soybean lecithin, Tween 80 and xanthan gum on the release of aroma compounds. Compared with other aroma compounds, ethyl acetate was more likely to be conserved in the solution system, while the amount of limonene released was the highest among these seven aroma compounds. In conclusion, different emulsifiers and complexes showed different surface properties that tend to interact with different aroma molecules. The present studies showed that the composition and structure of emulsifiers and specific interactions between emulsifiers and aroma molecules have significant effects on aroma release. Full article
(This article belongs to the Collection Recent Advances in Flavors and Fragrances)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Effects of Tween 80 on the release of ethyl acetate, (<span class="html-italic">E</span>)-2-hexenal, carvone (<b>a</b>) and perillaldehyde, α-pinene, 3-carene, limonene (<b>b</b>). Significant differences (<span class="html-italic">p</span> &lt; 0.05) between different concentrations are performed by letters on the same polylines. Where the letters on the same polyline are the same, there is no significant difference between different concentrations.</p>
Full article ">Figure 1 Cont.
<p>Effects of Tween 80 on the release of ethyl acetate, (<span class="html-italic">E</span>)-2-hexenal, carvone (<b>a</b>) and perillaldehyde, α-pinene, 3-carene, limonene (<b>b</b>). Significant differences (<span class="html-italic">p</span> &lt; 0.05) between different concentrations are performed by letters on the same polylines. Where the letters on the same polyline are the same, there is no significant difference between different concentrations.</p>
Full article ">Figure 2
<p>Effects of soybean lecithin on the release of ethyl acetate, (<span class="html-italic">E</span>)-2-hexenal, carvone (<b>a</b>) and perillaldehyde, α-pinene, 3-carene, limonene (<b>b</b>). Significant differences (<span class="html-italic">p</span> &lt; 0.05) between different concentrations are performed by letters on the same polylines. Where the letters on the same polyline are the same, there is no significant difference between different concentrations.</p>
Full article ">Figure 2 Cont.
<p>Effects of soybean lecithin on the release of ethyl acetate, (<span class="html-italic">E</span>)-2-hexenal, carvone (<b>a</b>) and perillaldehyde, α-pinene, 3-carene, limonene (<b>b</b>). Significant differences (<span class="html-italic">p</span> &lt; 0.05) between different concentrations are performed by letters on the same polylines. Where the letters on the same polyline are the same, there is no significant difference between different concentrations.</p>
Full article ">Figure 3
<p>Effects of sucrose fatty acid ester on the release of ethyl acetate, (<span class="html-italic">E</span>)-2-hexenal, carvone (<b>a</b>) and perillaldehyde, α-pinene, 3-carene, limonene (<b>b</b>). Significant differences (<span class="html-italic">p</span> &lt; 0.05) between different concentrations are performed by letters on the same polylines. Where the letters on the same polyline are the same, there is no significant difference between different concentrations.</p>
Full article ">Figure 3 Cont.
<p>Effects of sucrose fatty acid ester on the release of ethyl acetate, (<span class="html-italic">E</span>)-2-hexenal, carvone (<b>a</b>) and perillaldehyde, α-pinene, 3-carene, limonene (<b>b</b>). Significant differences (<span class="html-italic">p</span> &lt; 0.05) between different concentrations are performed by letters on the same polylines. Where the letters on the same polyline are the same, there is no significant difference between different concentrations.</p>
Full article ">Figure 4
<p>Effects of xanthan gum on the release of ethyl acetate, (<span class="html-italic">E</span>)-2-hexenal, carvone (<b>a</b>) and perillaldehyde, α-pinene, 3-carene, limonene (<b>b</b>). Significant differences (<span class="html-italic">p</span> &lt; 0.05) between different concentrations are performed by letters on the same polylines. Where the letters on the same polyline are the same, there is no significant difference between different concentrations.</p>
Full article ">Figure 5
<p>Effects of Tween 80 and xanthan gum on the release of ethyl acetate, (<span class="html-italic">E</span>)-2-hexenal, carvone (<b>a</b>) and perillaldehyde, α-pinene, 3-carene, limonene (<b>b</b>). Significant differences (<span class="html-italic">p</span> &lt; 0.05) between different concentrations are performed by letters on the same polylines. Where the letters on the same polyline are the same, there is no significant difference between different concentrations.</p>
Full article ">Figure 6
<p>Effects of soybean lecithin and xanthan gum on the release of ethyl acetate, (<span class="html-italic">E</span>)-2-hexenal, carvone (<b>a</b>) and perillaldehyde, α-pinene, 3-carene, limonene (<b>b</b>). Significant differences (<span class="html-italic">p</span> &lt; 0.05) between different concentrations are performed by letters on the same polylines. Where the letters on the same polyline are the same, there is no significant difference between different concentrations.</p>
Full article ">Figure 7
<p>Effects of sucrose fatty acid ester and xanthan gum on the release of ethyl acetate, (<span class="html-italic">E</span>)-2-hexenal, carvone, perillaldehyde (<b>a</b>) and α-pinene, 3-carene, limonene (<b>b</b>). Significant differences (<span class="html-italic">p</span> &lt; 0.05) between different concentrations are performed by letters on the same polylines. Where the letters on the same polyline are the same, there is no significant difference between different concentrations.</p>
Full article ">
1098 KiB  
Article
Comparison of Antioxidant Activities of Melanin Fractions from Chestnut Shell
by Zeng-Yu Yao and Jian-Hua Qi
Molecules 2016, 21(4), 487; https://doi.org/10.3390/molecules21040487 - 22 Apr 2016
Cited by 37 | Viewed by 7589
Abstract
Chestnut shell melanin can be used as a colorant and antioxidant, and fractionated into three fractions (Fr. 1, Fr. 2, and Fr. 3) with different physicochemical properties. Antioxidant activities of the fractions were comparatively evaluated for the first time. The fractions exhibited different [...] Read more.
Chestnut shell melanin can be used as a colorant and antioxidant, and fractionated into three fractions (Fr. 1, Fr. 2, and Fr. 3) with different physicochemical properties. Antioxidant activities of the fractions were comparatively evaluated for the first time. The fractions exhibited different antioxidative potential in different evaluation systems. Fr. 1, which is only soluble in alkaline water, had the strongest peroxidation inhibition and superoxide anion scavenging activity; Fr. 2, which is soluble in alkaline water and hydrophilic organic solvents but insoluble in neutral and acidic water, had the greatest power to chelate ferrous ions; and Fr. 3, which is soluble both in hydrophilic organic solvents and in water at any pH conditions, had the greatest hydroxyl (·OH) and 1,1-diphenyl-2-picryl-hydrazyl (DPPH·) radicals scavenging abilities, reducing power, and phenolic content. The pigment fractions were superior to butylated hydroxytolune (BHT) in ·OH and DPPH· scavenging and to ethylene diamine tetraacetic acid (EDTA) in the Fe2+–chelation. They were inferior to BHT in peroxidation inhibition and O2· scavenging and reducing power. However, BHT is a synthetic antioxidant and cannot play the colorant role. The melanin fractions might be used as effective biological antioxidant colorants. Full article
(This article belongs to the Section Natural Products Chemistry)
Show Figures

Figure 1

Figure 1
<p>Peroxidation of linoleic acid and the inhibition effects of pigment fractions from chestnut shell evaluated by FTC (<b>A</b>) and TBA (<b>B</b>) methods. The lower case letters above the curves and bars indicate significant differences between means (<span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 2
<p>Dose dependent hydroxyl radical (<b>A</b>) and superoxide anion radical (<b>B</b>) scavenging effects of pigment fractions from chestnut shell. The lower case letters on the right of the curves indicate significant differences between means at sample concentration of 200 and 1000 mg/L for hydroxyl radical superoxide and anion radical scavenging, respectively (<span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 3
<p>Contact time dependent DPPH· scavenging effects of pigment fractions from chestnut shell.</p>
Full article ">Figure 4
<p>Dose dependent reducing power of pigment fractions from chestnut shells. The lower case letters on the right of the curves indicate significant differences between means at sample concentration of 200 mg/L (<span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 5
<p>Dose-dependent metal chelating ability of pigment fractions from chestnut shell.</p>
Full article ">
1737 KiB  
Article
The Effects of Fungicide, Soil Fumigant, Bio-Organic Fertilizer and Their Combined Application on Chrysanthemum Fusarium Wilt Controlling, Soil Enzyme Activities and Microbial Properties
by Shuang Zhao, Xi Chen, Shiping Deng, Xuena Dong, Aiping Song, Jianjun Yao, Weimin Fang and Fadi Chen
Molecules 2016, 21(4), 526; https://doi.org/10.3390/molecules21040526 - 21 Apr 2016
Cited by 48 | Viewed by 7395
Abstract
Sustained monoculture often leads to a decline in soil quality, in particular to the build-up of pathogen populations, a problem that is conventionally addressed by the use of either fungicide and/or soil fumigation. This practice is no longer considered to be either environmentally [...] Read more.
Sustained monoculture often leads to a decline in soil quality, in particular to the build-up of pathogen populations, a problem that is conventionally addressed by the use of either fungicide and/or soil fumigation. This practice is no longer considered to be either environmentally sustainable or safe. While the application of organic fertilizer is seen as a means of combating declining soil fertility, it has also been suggested as providing some control over certain soil-borne plant pathogens. Here, a greenhouse comparison was made of the Fusarium wilt control efficacy of various treatments given to a soil in which chrysanthemum had been produced continuously for many years. The treatments comprised the fungicide carbendazim (MBC), the soil fumigant dazomet (DAZ), the incorporation of a Paenibacillus polymyxa SQR21 (P. polymyxa SQR21, fungal antagonist) enhanced bio-organic fertilizer (BOF), and applications of BOF combined with either MBC or DAZ. Data suggest that all the treatments evaluated show good control over Fusarium wilt. The MBC and DAZ treatments were effective in suppressing the disease, but led to significant decrease in urease activity and no enhancement of catalase activity in the rhizosphere soils. BOF including treatments showed significant enhancement in soil enzyme activities and microbial communities compared to the MBC and DAZ, evidenced by differences in bacterial/fungi (B/F) ratios, Shannon–Wiener indexes and urease, catalase and sucrase activities in the rhizosphere soil of chrysanthemum. Of all the treatments evaluated, DAZ/BOF application not only greatly suppressed Fusarium wilt and enhanced soil enzyme activities and microbial communities but also promoted the quality of chrysanthemum obviously. Our findings suggest that combined BOF with DAZ could more effectively control Fusarium wilt disease of chrysanthemum. Full article
(This article belongs to the Section Molecular Diversity)
Show Figures

Figure 1

Figure 1
<p>Chrysanthemum <span class="html-italic">Fusarium</span> wilt incidence (<b>a</b>) and disease reduction percentage (DRP) (<b>b</b>) as affected by exposure to the various treatments for between 30 to 90 days following transplantation after three croppings. The bars represent the mean and the whiskers the standard deviation. See footnote to <a href="#molecules-21-00526-t001" class="html-table">Table 1</a> for the treatment codes. Letters above the bars indicate a significant difference according to Duncan’s multiple range test at <span class="html-italic">p</span> &lt; 0.05 level.</p>
Full article ">Figure 2
<p>Enzyme activity: (<b>a</b>) Catalase; (<b>b</b>) Urease; and (<b>c</b>) Sucrose in soils sampled from plants experiencing the range of treatments. The bars represent the mean and the whiskers the standard deviation. See footnote to <a href="#molecules-21-00526-t001" class="html-table">Table 1</a> for the treatment codes. Letters above the bars indicate a significant difference according to Duncan’s multiple range test at <span class="html-italic">p</span> &lt; 0.05 level.</p>
Full article ">Figure 3
<p>DGGE profiling of soil microbiota: (<b>a</b>) the bacterial community; and (<b>b</b>) the fungal community. Numbered fragments were excised, re-amplified and sequenced. See footnote to <a href="#molecules-21-00526-t001" class="html-table">Table 1</a> for the treatment codes.</p>
Full article ">Figure 3 Cont.
<p>DGGE profiling of soil microbiota: (<b>a</b>) the bacterial community; and (<b>b</b>) the fungal community. Numbered fragments were excised, re-amplified and sequenced. See footnote to <a href="#molecules-21-00526-t001" class="html-table">Table 1</a> for the treatment codes.</p>
Full article ">
3153 KiB  
Article
Delivery of Gemcitabine Prodrugs Employing Mesoporous Silica Nanoparticles
by Alessio Malfanti, Ivana Miletto, Emanuela Bottinelli, Daniele Zonari, Giulia Blandino, Gloria Berlier and Silvia Arpicco
Molecules 2016, 21(4), 522; https://doi.org/10.3390/molecules21040522 - 21 Apr 2016
Cited by 33 | Viewed by 7674
Abstract
In this paper, mesoporous silica nanoparticles (MSNs) were studied as vehicles for the delivery of the antitumoral drug gemcitabine (GEM) and of its 4-(N)-acyl derivatives, (4-(N)-valeroyl-(C5GEM), 4-(N)-lauroyl-(C12GEM) and 4-(N)-stearoyl-gemcitabine (C18GEM)). The loading of the GEM [...] Read more.
In this paper, mesoporous silica nanoparticles (MSNs) were studied as vehicles for the delivery of the antitumoral drug gemcitabine (GEM) and of its 4-(N)-acyl derivatives, (4-(N)-valeroyl-(C5GEM), 4-(N)-lauroyl-(C12GEM) and 4-(N)-stearoyl-gemcitabine (C18GEM)). The loading of the GEM lipophilic prodrugs on MSNs was explored with the aim to obtain both a physical and a chemical protection of GEM from rapid plasmatic metabolization. For this purpose, MSNs as such or with grafted aminopropyl and carboxyethyl groups were prepared and characterized. Then, their different drug loading capacity in relation to the nature of the functional group was evaluated. In our experimental conditions, GEM was not loaded in any MSNs, while C12GEM was the most efficiently encapsulated and employed for further evaluation. The results showed that loading capacity increased with the presence of functional groups on the nanoparticles; similarly, the presence of functional groups on MSNs’ surface influenced the drug release profile. Finally, the cytotoxicity of the different preparations was evaluated and data showed that C12GEM loaded MSNs are less cytotoxic than the free drug with an activity that increased with the incubating time, indicating that all these systems are able to release the drug in a controlled manner. Altogether, the results demonstrate that these MSNs could be an interesting system for the delivery of anticancer drugs. Full article
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>HRTEM images of (<b>A</b>) MSN; (<b>B</b>) Carboxy-MSN; (<b>C</b>) Amino-MSN.</p>
Full article ">Figure 2
<p>Ball and stick representation of gemcitabine and its prodrugs: carbon atoms are in grey, oxygen in red, nitrogen in violet, fluorine in light blue, hydrogen in light grey. Visualization and fast geometry optimization were obtained with the Discovery Studio Visualizer software (v.16.1.0.15350, San Diego, CA, USA of Biovia), by employing a Dreiding-like forcefield.</p>
Full article ">Figure 3
<p><span class="html-italic">In vitro</span> release profiles of MSN-C12GEM ■ Amino-MSN-C12GEM ▲ and Carboxy-MSN-C12GEM ● in PBS medium at 37 °C. All experiments were done in triplicate. SD: ±10%.</p>
Full article ">Figure 4
<p>Cytotoxicity of (<b>A</b>) unloaded MSNs; and (<b>B</b>) C12 GEM loaded MSNs against MDA-MB-231 cells after 72 h of incubation.</p>
Full article ">Figure 5
<p>Cytotoxicity of unloaded (<b>A</b>) MSNs; and (<b>B</b>) C12 GEM loaded MSNs against A2780 cells after 72 h of incubation.</p>
Full article ">Figure 6
<p>(<b>Top</b>) nitrogen adsorption and desorption isotherms on (<b>a</b>) MSN; (<b>b</b>) Carboxy-MSN; and (<b>c</b>) Amino-MSN; (<b>Bottom</b>) corresponding pore size distributions.</p>
Full article ">Figure 7
<p>TGA profiles of (<b>a</b>) MSN; (<b>b</b>) Carboxy-MSN; and (<b>c</b>) Amino-MSN.</p>
Full article ">Figure 8
<p>Powder XRD patterns of MSNs (<b>curve a, black line</b>), Carboxy-MSNs (<b>curve b, blue line</b>) and Amino-MSNs (<b>curve c, red line</b>).</p>
Full article ">Figure 9
<p>FTIR spectra in the high and low frequency region (top and bottom, respectively) of: (<b>a</b>) MSN; (<b>b</b>) Carboxy-MSN; and (<b>c</b>) Amino-MSN.</p>
Full article ">
1390 KiB  
Article
Sorption Kinetics on Open Carbon Nanohorn Aggregates: The Effect of Molecular Diameter
by Brice A. Russell, Pravin Khanal, Maria M. Calbi, Masako Yudasaka, Sumio Iijima and Aldo D. Migone
Molecules 2016, 21(4), 521; https://doi.org/10.3390/molecules21040521 - 21 Apr 2016
Cited by 6 | Viewed by 5246
Abstract
We present the results of a study of the kinetics of adsorption on aggregates of open carbon nanohorns using argon and CF4 sorbates. We measured the equilibration times for each value of the sorbent loading along eight adsorption isotherms (four isotherms for [...] Read more.
We present the results of a study of the kinetics of adsorption on aggregates of open carbon nanohorns using argon and CF4 sorbates. We measured the equilibration times for each value of the sorbent loading along eight adsorption isotherms (four isotherms for each sorbate species). We found that: the equilibration times decrease as the sorbent loading (and the equilibrium pressure of the coexisting gas) increases, for a given temperature; and, that, for a given value of the sorbent loading, the equilibration times decrease with increasing temperature. When considering the effect of scaling of the temperatures by the respective critical temperatures we found that, at the same scaled temperature and at comparable loadings, the equilibration times for CF4 were longer than those for argon. We discuss a possible explanation for this result. Full article
(This article belongs to the Special Issue Carbon Nanotubes: Advances and Applications)
Show Figures

Figure 1

Figure 1
<p>TEM images of carbon nanohorns. (<b>a</b>) a dahlia-like aggregate; and (<b>b</b>) the magnified image of the individual nanohorn tips. The figure is reproduced from reference [<a href="#B13-molecules-21-00521" class="html-bibr">13</a>].</p>
Full article ">Figure 2
<p>Adsorption isotherm for Ar on the chemically-opened nanohorns at 76.32 K. The arrows indicate (from the lowest to the highest) adsorption on the high energy binding sites, the low energy binding sites, and the saturated vapor pressure. The amount sorbed is in millimoles.</p>
Full article ">Figure 3
<p>Approach to equilibrium for point 6 along the 82.07 K isotherm for Ar on the open nanohorns (the point numbers start at 1 with the point at the lowest loading, 2 for the next one, <span class="html-italic">etc.</span>). (<b>a</b>) Absolute pressure (in Torr, Y axis) as a function of the time elapsed (in seconds) since a dose of gas was added; and (<b>b</b>) fractional pressure distance to equilibrium [(P(t) − P<sub>eq</sub>)/P<sub>eq</sub>] as a function of time elapsed since dosing (data shown for (<b>b</b>) start ~40 min after the dose was added). From (<b>b</b>) it is clear that the noise level in the pressure is reached only after ~2 h have elapsed.</p>
Full article ">Figure 4
<p>Mass loading as a function of time elapsed using an expression derived from Equation (1) for two points along the 82.07 K isotherm (top panel for point 8 along the isotherm; bottom panel for point 11 along the isotherm). If the linear driving force model were to describe the data accurately, the plots should be straight lines. With the exception of the initial times, the linear driving force model does an adequate job of describing the data.</p>
Full article ">Figure 5
<p>Time required to reach 99% of the equilibrium mass loading (in seconds) as a function of the mass loading at equilibrium for the four temperatures studied 76.32 (<b>blue</b>), 82.07 (<b>purple</b>), 86.87 (<b>black</b>), and 91.18 K (red) for argon on aggregates of open nanohorns.</p>
Full article ">Figure 6
<p>Adsorption isotherm for CF<sub>4</sub> on aggregates of open carbon nanohorns at T = 118.95 K. The arrows, from top to bottom, indicate saturation, sorption on weak binding energy sites, and sorption on strong binding energy sites present on the sorbent.</p>
Full article ">Figure 7
<p>Equilibration times, in seconds, are measured at the point when the sorbent loading reaches 99% of the sorbent loading at equilibrium for the four temperatures studied, as a function of the loading at equilibrium for CF<sub>4</sub>.</p>
Full article ">
1664 KiB  
Review
Natural Phytochemicals in the Treatment and Prevention of Dementia: An Overview
by Rosaliana Libro, Sabrina Giacoppo, Thangavelu Soundara Rajan, Placido Bramanti and Emanuela Mazzon
Molecules 2016, 21(4), 518; https://doi.org/10.3390/molecules21040518 - 21 Apr 2016
Cited by 75 | Viewed by 18687
Abstract
The word dementia describes a class of heterogeneous diseases which etiopathogenetic mechanisms are not well understood. There are different types of dementia, among which, Alzheimer’s disease (AD), vascular dementia (VaD), dementia with Lewy bodies (DLB) and frontotemporal dementia (FTD) are the more common. [...] Read more.
The word dementia describes a class of heterogeneous diseases which etiopathogenetic mechanisms are not well understood. There are different types of dementia, among which, Alzheimer’s disease (AD), vascular dementia (VaD), dementia with Lewy bodies (DLB) and frontotemporal dementia (FTD) are the more common. Currently approved pharmacological treatments for most forms of dementia seem to act only on symptoms without having profound disease-modifying effects. Thus, alternative strategies capable of preventing the progressive loss of specific neuronal populations are urgently required. In particular, the attention of researchers has been focused on phytochemical compounds that have shown antioxidative, anti-amyloidogenic, anti-inflammatory and anti-apoptotic properties and that could represent important resources in the discovery of drug candidates against dementia. In this review, we summarize the neuroprotective effects of the main phytochemicals belonging to the polyphenol, isothiocyanate, alkaloid and cannabinoid families in the prevention and treatment of the most common kinds of dementia. We believe that natural phytochemicals may represent a promising sources of alternative medicine, at least in association with therapies approved to date for dementia. Full article
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Molecular structure of curcumin.</p>
Full article ">Figure 2
<p>Molecular structure of resveratrol.</p>
Full article ">Figure 3
<p>Molecular structure of epigallocatechin-3-gallate.</p>
Full article ">Figure 4
<p>Molecular structure of sulforaphane.</p>
Full article ">Figure 5
<p>Molecular structure of moringin.</p>
Full article ">Figure 6
<p>Chemical structures of some alkaloids: (<b>A</b>) berberine; (<b>B</b>) caffeine; (<b>C</b>) galantamine; (<b>D</b>) huperzine A; (<b>E</b>) morphine; (<b>F</b>) nicotine; (<b>G</b>) rivastigmine.</p>
Full article ">Figure 7
<p>Molecular structure of cannabidiol.</p>
Full article ">
3370 KiB  
Article
Sulforaphane Analogues with Heterocyclic Moieties: Syntheses and Inhibitory Activities against Cancer Cell Lines
by Ye-Hui Shi, Dong-Fang Dai, Jing Li, Yan-Wei Dong, Yin Jiang, Huan-Gong Li, Yuan Gao, Chuan-Ke Chong, Hui-Ying Li, Xiao-Qian Chu, Cheng Yang, Quan Zhang, Zhong-Sheng Tong, Cui-Gai Bai and Yue Chen
Molecules 2016, 21(4), 514; https://doi.org/10.3390/molecules21040514 - 21 Apr 2016
Cited by 12 | Viewed by 6654
Abstract
Recent studies have shown that sulforaphane (SFN) selectively inhibits the growth of ALDH+ breast cancer stem-like cells.Herein, a series of SFN analogues were synthesized and evaluated against breast cancer cell lines MCF-7 and SUM-159, and the leukemia stem cell-like cell line KG-1a. [...] Read more.
Recent studies have shown that sulforaphane (SFN) selectively inhibits the growth of ALDH+ breast cancer stem-like cells.Herein, a series of SFN analogues were synthesized and evaluated against breast cancer cell lines MCF-7 and SUM-159, and the leukemia stem cell-like cell line KG-1a. These SFN analogues were characterized by the replacement of the methyl group with heterocyclic moieties, and the replacement of the sulfoxide group with sulfide or sulfone. A growth inhibitory assay indicated that the tetrazole analogs 3d, 8d and 9d were significantly more potent than SFN against the three cancer cell lines. Compound 14c, the water soluble derivative of tetrazole sulfide 3d, demonstrated higher potency against KG-1a cell line than 3d. SFN, 3d and 14c significantly induced the activation of caspase-3, and reduced the ALDH+ subpopulation in the SUM159 cell line, while the marketed drug doxrubicin(DOX) increased the ALDH+ subpopulation. Full article
(This article belongs to the Collection Heterocyclic Compounds)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>SFN, <b>3d</b> and <b>14c</b> enhanced caspase-3 activity in SUM-159 cells.</p>
Full article ">Figure 2
<p>Inhibitory effects of SFN, <b>3d</b> and <b>14c</b> on ALDH-positive cell subpopulation.</p>
Full article ">Scheme 1
<p>Synthesis of isothiocyanates <b>3a</b>–<b>e</b>. <span class="html-italic">Reagents and conditions</span>: (i) Me-NH<sub>2</sub>, MeOH, r.t., 70%–85% (ii) CSCl<sub>2</sub>, NaOH (aq, 1 mol/L), CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to r.t., 37%–81%.</p>
Full article ">Scheme 2
<p>Synthesis of isothiocyanates <b>8a</b>–<b>c</b> and <b>9a</b>–<b>c</b>. <span class="html-italic">Reagents and conditions</span>: (i) TBHP, Ti(O-i-Pr)<sub>4</sub>, CH<sub>2</sub>Cl<sub>2</sub>, −20 to −10 °C, 58%–95%; (ii) Me-NH<sub>2</sub>, MeOH, r.t., 48%–64%; (iii) CSCl<sub>2</sub>, NaOH (aq, 1 mol/L), CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to r.t., 53%–80%.</p>
Full article ">Scheme 3
<p>Synthesis of isothiocyanates <b>8</b><b>d</b>–<b>e</b>. <span class="html-italic">Reagents and conditions</span>: (i) <span class="html-italic">m</span>-CPBA, CH<sub>2</sub>Cl<sub>2</sub>, r.t., Yield: <b>8d</b>: 20% and <b>8</b><b>e</b>: 40%.</p>
Full article ">Scheme 4
<p>Synthesis of isothiocyanates <b>9d</b>–<b>e</b>. <span class="html-italic">Reagents and conditions</span>: (i) (Boc)<sub>2</sub>O, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, r.t., Yield: <b>10d</b>: 63% and <b>10</b><b>e</b>: 77%; (ii) TBHP, Ti(O-i-Pr)<sub>4</sub>, CH<sub>2</sub>Cl<sub>2</sub>, r.t., Yield: <b>11d</b>: 73% and <b>11</b><b>e</b>: 94%; (iii) CF<sub>3</sub>COOH, CH<sub>2</sub>Cl<sub>2</sub>, NaOH (aq,1 mol/L), r.t., crude; (iv) CSCl<sub>2</sub>, NaOH (aq,1 mol/L), CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to r.t., Yield: <b>9d</b>: 15% and <b>9</b><b>e</b>: 22%.</p>
Full article ">Scheme 5
<p>Synthesis of water soluble derivatives <b>14a</b>–<b>c</b>. <span class="html-italic">Reagents and conditions</span>: (i) for <b>14a</b>–<b>b</b>: DMAP, CH<sub>2</sub>Cl<sub>2</sub>, r.t., Yield: <b>14a</b>: 16% and <b>14b</b>: 23%; (ii) for <b>14c</b>: EtOH, NaOH (aq.), 40 °C, r.t., 20%.</p>
Full article ">
1657 KiB  
Article
The Effect of an Optimized Wet Milling Technology on the Crystallinity, Morphology and Dissolution Properties of Micro- and Nanonized Meloxicam
by Csilla Bartos, Piroska Szabó-Révész, Csaba Bartos, Gábor Katona, Orsolya Jójárt-Laczkovich and Rita Ambrus
Molecules 2016, 21(4), 507; https://doi.org/10.3390/molecules21040507 - 21 Apr 2016
Cited by 32 | Viewed by 5941
Abstract
This article reports on the effects of a new combined wet milling technique on the physicochemical properties of meloxicam (MEL). The influence of milling time on the particle size, the crystallinity, the morphology and the dissolution rate of MEL has been studied in [...] Read more.
This article reports on the effects of a new combined wet milling technique on the physicochemical properties of meloxicam (MEL). The influence of milling time on the particle size, the crystallinity, the morphology and the dissolution rate of MEL has been studied in the presence and absence of polyvinyl alcohol (PVA) as a stabilizer agent. Micronized MEL particles were produced in aqueous medium which did not contain additive after milling for 10 min. For nanonization an additive and longer milling time were required. After particle size determination the structural and morphological characterization of the wet milled, dried products containing MEL were studied. X-ray powder diffractometry (XRPD) and differential scanning calorimetry (DSC) examinations revealed the change in the crystallinity of MEL. Scanning electron microscopy (SEM) images showed that aggregates of nanosized MEL particles were formed, regardless of the presence of PVA. The nanonized MEL crystals (D50 = 126 nm) exhibited a regular shape and a smooth surface. The increased specific surface area resulted in a high dissolution rate and concentration of free MEL. According to the results, the produced samples could be applied as a basic material (micronized MEL) and intermediate product (micronized and nanonized MEL with PVA) for the design of dosage forms. Full article
(This article belongs to the Special Issue Crystallization of Pharmaceuticals)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>XRPD examination of MEL_raw and MEL_PVA_pm.</p>
Full article ">Figure 2
<p>XRPD examination of MEL_W 10 min, MEL_W_PVA 10 min and MEL_W_PVA 50 min.</p>
Full article ">Figure 3
<p>DSC curves of MEL_raw, MEL_PVA_pm, MEL_W 10 min, MEL_W_PVA 10 min and MEL_W_PVA 50 min.</p>
Full article ">Figure 4
<p>SEM pictures of MEL_raw (<b>A</b>); MEL_W 10 min (<b>B</b>); MEL_W_PVA 10 min (<b>C</b>) and MEL_W_PVA 50 min (<b>D</b>).</p>
Full article ">Figure 5
<p><span class="html-italic">In vitro</span> dissolution profile of MEL_raw, MEL_PVA_pm, MEL_W 10 min, MEL_W_PVA 10 min and MEL_W_PVA 50 min (SD &lt; 0.05%).</p>
Full article ">
5351 KiB  
Article
Antimicrobial Lemongrass Essential Oil—Copper Ferrite Cellulose Acetate Nanocapsules
by Ioannis L. Liakos, Mohamed H. Abdellatif, Claudia Innocenti, Alice Scarpellini, Riccardo Carzino, Virgilio Brunetti, Sergio Marras, Rosaria Brescia, Filippo Drago and Pier Paolo Pompa
Molecules 2016, 21(4), 520; https://doi.org/10.3390/molecules21040520 - 20 Apr 2016
Cited by 26 | Viewed by 8699
Abstract
Cellulose acetate (CA) nanoparticles were combined with two antimicrobial agents, namely lemongrass (LG) essential oil and Cu-ferrite nanoparticles. The preparation method of CA nanocapsules (NCs), with the two antimicrobial agents, was based on the nanoprecipitation method using the solvent/anti-solvent technique. Several physical and [...] Read more.
Cellulose acetate (CA) nanoparticles were combined with two antimicrobial agents, namely lemongrass (LG) essential oil and Cu-ferrite nanoparticles. The preparation method of CA nanocapsules (NCs), with the two antimicrobial agents, was based on the nanoprecipitation method using the solvent/anti-solvent technique. Several physical and chemical analyses were performed to characterize the resulting NCs and to study their formation mechanism. The size of the combined antimicrobial NCs was found to be ca. 220 nm. The presence of Cu-ferrites enhanced the attachment of LG essential oil into the CA matrix. The magnetic properties of the combined construct were weak, due to the shielding of Cu-ferrites from the polymeric matrix, making them available for drug delivery applications where spontaneous magnetization effects should be avoided. The antimicrobial properties of the NCs were significantly enhanced with respect to CA/LG only. This work opens novel routes for the development of organic/inorganic nanoparticles with exceptional antimicrobial activities. Full article
(This article belongs to the Special Issue Pharmaceutical Nanotechnology: Novel Approaches)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>DLS measurements of the size, polydispersity index (PdI) and intensity % of the Cellulose acetate (CA) nanoparticles, CA/5-lemongrass (LG), CA/Cu-ferrite and CA/5-LG/Cu-ferrite nanocapsules (NCs).</p>
Full article ">Figure 2
<p>XRD pattern of Cu-ferrite NPs.</p>
Full article ">Figure 3
<p>AFM topography of (<b>a</b>) CA/5-LG NCs and (<b>b</b>) CA/5-LG/Cu-ferrite NCs.</p>
Full article ">Figure 4
<p>(<b>a</b>) SEM of Cu-ferrite NPs (in the inset, particles of <span class="html-italic">ca.</span> 70 nm are highlighted with red bars); (<b>b</b>) SEM of CA/5-LG/Cu-ferrite NCs; (<b>c</b>) TEM of Cu-ferrite NPs; (<b>d</b>) TEM of CA/5-LG NCs; and (<b>e</b>) TEM of CA/5-LG/Cu-ferrite NCs.</p>
Full article ">Figure 5
<p>(<b>a</b>) HAADF-STEM and (<b>b</b>–<b>e</b>) corresponding STEM-EDS maps of Fe, Cu, O and C distribution over a region of the sample. The quantification of the (<b>f</b>) corresponding EDS spectrum gives atomic wt % Cu:Fe:O:C = 0.5:0.98:1.0:97.52; (<b>g</b>) SAED pattern from Cu-ferrite NPs and (<b>h</b>) corresponding azimuthal integration, compared to the database pattern for tetragonal CuFe2O4 (ICSD 188855).</p>
Full article ">Figure 6
<p>Magnetization curve of (<b>a</b>) Cu-ferrite nanopowder and (<b>b</b>) lyophilized CA/5-LG/Cu-ferrite NCs measured at 5 K and 300 K; the insets show a magnification of the corresponding hysteresis loop in the low field range.</p>
Full article ">Figure 7
<p>Raman spectra of LG essential oil (blue dots), CA/Cu-ferrite NCs (black dashed line) and CA/5-LG/Cu-ferrite NCs (brown line).</p>
Full article ">Figure 8
<p>(<b>a</b>) UV-VIS absorption spectra of the 10-μL CA/5-LG/Cu-ferrite NC and 50-μL CA/5-LG NC solution and (<b>b</b>) the calibration curve and calculation of LG oil content in 10 μL CA/5-LG/Cu-ferrite and 50 μL CA/5-LG NCs.</p>
Full article ">Figure 9
<p>Molecular diagram of the reactions that can take place between aldehyde molecules, Cu-ferrite NPs and the hydroxyl group of the cellulose acetate ring to produce electrostatic bonds and hemiacetal bonds, respectively. The reactions between the Cu-ferrite NP with the acetyl group (R) and/or OH group of CA are also visible, where R is OC(=O)CH<sub>3</sub>.</p>
Full article ">Figure 10
<p>Antimicrobial activity of CA/5-LG, CA/Cu-ferrite and CA/5-LG/Cu-ferrite NCs.</p>
Full article ">
9278 KiB  
Article
Anti-Inflammatory Activities of Pentaherbs Formula, Berberine, Gallic Acid and Chlorogenic Acid in Atopic Dermatitis-Like Skin Inflammation
by Miranda S. M. Tsang, Delong Jiao, Ben C. L. Chan, Kam-Lun Hon, Ping C. Leung, Clara B. S. Lau, Eric C. W. Wong, Ling Cheng, Carmen K. M. Chan, Christopher W. K. Lam and Chun K. Wong
Molecules 2016, 21(4), 519; https://doi.org/10.3390/molecules21040519 - 20 Apr 2016
Cited by 109 | Viewed by 15975
Abstract
Atopic dermatitis (AD) is a common allergic skin disease, characterized by dryness, itchiness, thickening and inflammation of the skin. Infiltration of eosinophils into the dermal layer and presence of edema are typical characteristics in the skin biopsy of AD patients. Previous in vitro [...] Read more.
Atopic dermatitis (AD) is a common allergic skin disease, characterized by dryness, itchiness, thickening and inflammation of the skin. Infiltration of eosinophils into the dermal layer and presence of edema are typical characteristics in the skin biopsy of AD patients. Previous in vitro and clinical studies showed that the Pentaherbs formula (PHF) consisting of five traditional Chinese herbal medicines, Flos Lonicerae, Herba Menthae, Cortex Phellodendri, Cortex Moutan and Rhizoma Atractylodis at w/w ratio of 2:1:2:2:2 exhibited therapeutic potential in treating AD. In this study, an in vivo murine model with oxazolone (OXA)-mediated dermatitis was used to elucidate the efficacy of PHF. Active ingredients of PHF water extract were also identified and quantified, and their in vitro anti-inflammatory activities on pruritogenic cytokine IL-31- and alarmin IL-33-activated human eosinophils and dermal fibroblasts were evaluated. Ear swelling, epidermis thickening and eosinophils infiltration in epidermal and dermal layers, and the release of serum IL-12 of the murine OXA-mediated dermatitis were significantly reduced upon oral or topical treatment with PHF (all p < 0.05). Gallic acid, chlorogenic acid and berberine contents (w/w) in PHF were found to be 0.479%, 1.201% and 0.022%, respectively. Gallic acid and chlorogenic acid could suppress the release of pro-inflammatory cytokine IL-6 and chemokine CCL7 and CXCL8, respectively, in IL-31- and IL-33-treated eosinophils-dermal fibroblasts co-culture; while berberine could suppress the release of IL-6, CXCL8, CCL2 and CCL7 in the eosinophil culture and eosinophils-dermal fibroblasts co-culture (all p < 0.05). These findings suggest that PHF can ameliorate allergic inflammation and attenuate the activation of eosinophils. Full article
(This article belongs to the Collection Herbal Medicine Research)
Show Figures

Figure 1

Figure 1
<p>Oral treatment of Pentaherbs formula (PHF) could relieve <span class="html-italic">in vivo</span> oxazolone (OXA)-mediated dermatitis of mouse ears. A single challenge OXA-mediated dermatitis murine model was established by administering OXA on mice ears after sensitization. PHF (15 mg) in 0.3 mL PBS was orally administered or topically applied on mice ears from Day 1 to Day 6. Dexamethasone (2.5 mg/mL) was topically applied on mice ears as positive control. (<b>A</b>–<b>F</b>) Representative photographs of ear redness were taken on Day 9 before mice were sacrificed (<span class="html-italic">n</span> = 6).</p>
Full article ">Figure 2
<p>Oral intake of PHF could reduce the ear tissue swelling of mice with OXA-mediated dermatitis. A single challenge OXA-mediated dermatitis murine model was established by administering OXA on mouse ears after sensitization. PHF (15 mg) in 0.3 mL PBS was orally administered or topically applied on mouse ears from Day 1 to Day 6. Dexamethasone (2.5 mg/mL) was applied topically on mouse ears as positive control. (<b>A</b>–<b>F</b>) Representative hematoxylin and eosin stain (H &amp; E) staining, which denoted the thickness of challenged ear (right ear) tissues, was performed on Day 16 (100×) (<span class="html-italic">n</span> = 4).</p>
Full article ">Figure 3
<p>Oral intake and topical application of PHF could significantly reduce the thickness of ear epidermal layer of mice with OXA-mediated dermatitis. A single challenge OXA-mediated dermatitis murine model was established by administering OXA on mouse ears after sensitization. PHF (15 mg) in 0.3 mL PBS was orally administered or topically applied on mouse ears from Day 1 to Day 6. Dexamethasone (2.5 mg/mL) was topically applied on mouse ears as positive control; (<b>A</b>–<b>F</b>) Representative H &amp; E staining of challenged ear (right ear) was performed on Day 16 (400×). Black arrows depict the epidermal layer of the ear tissue; (<b>G</b>) The ear epidermal thickness was measured and shown in bar chart with mean ± SEM (<span class="html-italic">n</span> = 6). <b>*</b> <span class="html-italic">p</span> &lt; 0.05 when compared with the OXA control group; n.s.: no significant difference when compared with the OXA control group.</p>
Full article ">Figure 3 Cont.
<p>Oral intake and topical application of PHF could significantly reduce the thickness of ear epidermal layer of mice with OXA-mediated dermatitis. A single challenge OXA-mediated dermatitis murine model was established by administering OXA on mouse ears after sensitization. PHF (15 mg) in 0.3 mL PBS was orally administered or topically applied on mouse ears from Day 1 to Day 6. Dexamethasone (2.5 mg/mL) was topically applied on mouse ears as positive control; (<b>A</b>–<b>F</b>) Representative H &amp; E staining of challenged ear (right ear) was performed on Day 16 (400×). Black arrows depict the epidermal layer of the ear tissue; (<b>G</b>) The ear epidermal thickness was measured and shown in bar chart with mean ± SEM (<span class="html-italic">n</span> = 6). <b>*</b> <span class="html-italic">p</span> &lt; 0.05 when compared with the OXA control group; n.s.: no significant difference when compared with the OXA control group.</p>
Full article ">Figure 4
<p>Oral intake and topical application of PHF could reduce the infiltration of eosinophils into the epidermal and dermal layers of mice with OXA-mediated dermatitis. A single challenge OXA-mediated dermatitis murine model was established by administering OXA on mice ears after sensitization. PHF (15 mg) in 0.3 mL PBS was orally administered or topically applied on mouse ears from Day 1 to Day 6. Dexamethasone (2.5 mg/mL) was topically applied on mouse ears as positive control. (<b>A</b>–<b>F</b>) Representative H &amp; E staining of the epidermal and dermal layers of challenged ear (right ear) was performed on Day 16 (400×). Red arrows point to the infiltrated eosinophils at epidermal and dermal layers; (<b>G</b>) The number of eosinophils infiltrated into the epidermal and dermal layers was counted and shown in bar chart with mean ± SEM (<span class="html-italic">n</span> = 6). <b>*</b> <span class="html-italic">p</span> &lt; 0.05, <b>**</b> <span class="html-italic">p</span> &lt; 0.01 when compared with the OXA control group; n.s.: no significant difference when compared with the OXA control group.</p>
Full article ">Figure 5
<p>Effect of PHF on the serum concentrations of AD-related inflammatory cytokines and chemokines. A single challenge OXA-mediated dermatitis murine model was established by administering OXA on mice ears after sensitization. PHF (15 mg) in 0.3 mL PBS was orally administered or topically applied on mice ears from Day 1 to Day 6. Dexamethasone (2.5 mg/mL) was topically applied on mice ears as positive control. Serum was obtained on Day 9 after treatments for the determination of concentration of (<b>A</b>) KC; (<b>B</b>) IL-12 (p70); (<b>C</b>) IL-1β; (<b>D</b>) TNF-α and (<b>E</b>) MIP-2. Results are shown in bar chart with mean ± SEM (<span class="html-italic">n</span> = 6). <b>*</b> <span class="html-italic">p</span> &lt; 0.05, <b>**</b> <span class="html-italic">p</span> &lt; 0.01 when compared with the OXA control group; n.s.: no significant difference when compared with OXA control group.</p>
Full article ">Figure 6
<p>Effects of topical application of PHF on ears of mice with OXA-mediated dermatitis with 10 times OXA challenge. An OXA-mediated AD-like murine model was established by administering OXA on mouse ears ten times after sensitization. PHF (50 mg/mL cream) or cream vehicle (mixture of wool fat and Vaseline) was topically applied on mouse ears from Day 1 to Day 25 every other day. Dexamethasone (10 µg/ear) was applied topically on mouse ears as positive control from Day 16 to Day 26. (<b>A</b>) Representative photographs of ear redness of mice with different treatments were taken on Day 27 before mice were sacrificed (<span class="html-italic">n</span> = 6); (<b>B</b>) The ear thickness was measured and shown with mean ± SEM (<span class="html-italic">n</span> = 6) upon different treatments. <b>*</b> <span class="html-italic">p</span> &lt; 0.05, <b>**</b> <span class="html-italic">p</span> &lt; 0.01 when comparing the PHF treatment group with the OXA control group; (<b>C</b>) Representative H &amp; E staining of the epidermal and dermal layers of challenged ear (right ear) was performed on Day 32 (100×) upon different treatments; (<b>D</b>) The ear epidermis thickness was measured using ImageJ, and shown in bar chart with mean ± SEM (<span class="html-italic">n</span> = 6). <b>*</b> <span class="html-italic">p</span> &lt; 0.05, <b>**</b> <span class="html-italic">p</span> &lt; 0.01, <b>***</b> <span class="html-italic">p</span> &lt; 0.0001 when compared with the OXA control group; (<b>E</b>) Representative H &amp; E staining of the epidermal and dermal layers of challenged ear (right ear) of mice was performed on Day 32 (400×) upon different treatments. Yellow arrows point to the infiltrated eosinophils at the dermal layer; (<b>F</b>) Representative toluidine blue staining of the epidermal and dermal layers of challenged ear (right ear) of mice with different treatments was performed on Day 32 at 200× and at 400× magnifications. Red arrows point to the infiltrated mast cells at the dermal layer.</p>
Full article ">Figure 6 Cont.
<p>Effects of topical application of PHF on ears of mice with OXA-mediated dermatitis with 10 times OXA challenge. An OXA-mediated AD-like murine model was established by administering OXA on mouse ears ten times after sensitization. PHF (50 mg/mL cream) or cream vehicle (mixture of wool fat and Vaseline) was topically applied on mouse ears from Day 1 to Day 25 every other day. Dexamethasone (10 µg/ear) was applied topically on mouse ears as positive control from Day 16 to Day 26. (<b>A</b>) Representative photographs of ear redness of mice with different treatments were taken on Day 27 before mice were sacrificed (<span class="html-italic">n</span> = 6); (<b>B</b>) The ear thickness was measured and shown with mean ± SEM (<span class="html-italic">n</span> = 6) upon different treatments. <b>*</b> <span class="html-italic">p</span> &lt; 0.05, <b>**</b> <span class="html-italic">p</span> &lt; 0.01 when comparing the PHF treatment group with the OXA control group; (<b>C</b>) Representative H &amp; E staining of the epidermal and dermal layers of challenged ear (right ear) was performed on Day 32 (100×) upon different treatments; (<b>D</b>) The ear epidermis thickness was measured using ImageJ, and shown in bar chart with mean ± SEM (<span class="html-italic">n</span> = 6). <b>*</b> <span class="html-italic">p</span> &lt; 0.05, <b>**</b> <span class="html-italic">p</span> &lt; 0.01, <b>***</b> <span class="html-italic">p</span> &lt; 0.0001 when compared with the OXA control group; (<b>E</b>) Representative H &amp; E staining of the epidermal and dermal layers of challenged ear (right ear) of mice was performed on Day 32 (400×) upon different treatments. Yellow arrows point to the infiltrated eosinophils at the dermal layer; (<b>F</b>) Representative toluidine blue staining of the epidermal and dermal layers of challenged ear (right ear) of mice with different treatments was performed on Day 32 at 200× and at 400× magnifications. Red arrows point to the infiltrated mast cells at the dermal layer.</p>
Full article ">Figure 7
<p>HPLC profiles of: (<b>A</b>) a standard mixture consisting of pure compounds Gallic acid, chlorogenic acid and berberine detected at UV 266 nm and (<b>B</b>) at UV 327 nm; (<b>C</b>) bioactive markers of Gallic acid and berberine in PHF water extract detected at UV 266 nm; and (<b>D</b>) bioactive marker of chlorogenic acid in PHF water extract detected at UV 327 nm. Representative retention time peaks and percentage content of the bioactive markers are shown.</p>
Full article ">Figure 7 Cont.
<p>HPLC profiles of: (<b>A</b>) a standard mixture consisting of pure compounds Gallic acid, chlorogenic acid and berberine detected at UV 266 nm and (<b>B</b>) at UV 327 nm; (<b>C</b>) bioactive markers of Gallic acid and berberine in PHF water extract detected at UV 266 nm; and (<b>D</b>) bioactive marker of chlorogenic acid in PHF water extract detected at UV 327 nm. Representative retention time peaks and percentage content of the bioactive markers are shown.</p>
Full article ">Figure 8
<p><span class="html-italic">In vitro</span> effect of: (<b>A</b>) IL-6; (<b>B</b>) CXCL8; (<b>C</b>) CCL2; (<b>D</b>) CCL7; and (<b>E</b>) TNF-α release from IL-31- and IL-33-activated human eosinophils treated with berberine (Ber). Eosinophils (3 × 10<sup>5</sup>) was pretreated with or without Ber (5, 10 and 25 µg/mL) and then cultured with or without human recombinant IL-31 and IL-33 (100 ng/mL) for 18 h. Release of cytokines and chemokines in culture supernatants was determined by ELISA and Bio-plex pro assay. Results are shown in bar charts with mean ± SEM (<span class="html-italic">n</span> = 4). <b>*</b> <span class="html-italic">p</span> &lt; 0.05, <b>**</b> <span class="html-italic">p</span> &lt; 0.01, <b>***</b> <span class="html-italic">p</span> &lt; 0.005 when compared with the IL-31- and IL-33-stimulated group.</p>
Full article ">Figure 9
<p><span class="html-italic">In vitro</span> effect of: (<b>A</b>) IL-6; (<b>B</b>) CCL2; and (<b>C</b>) CXCL8 release from IL-31- and IL-33-activated human eosinophils-dermal fibroblasts co-culture treated with berberine (Ber). Eosinophils (3 × 10<sup>5</sup>) and dermal fibroblast (8 × 10<sup>4</sup>) were pre-treated with or without Ber (5, 10, 25 and 50 µg/mL) and then cultured with or without human recombinant IL-31 and IL-33 (100 ng/mL) for further 18 h. Release of AD-related cytokine and chemokines in culture supernatants was determined by ELISA. Results are shown in bar charts with mean ± SEM (<span class="html-italic">n</span> = 5). <b>**</b> <span class="html-italic">p</span> &lt; 0.01, <b>***</b> <span class="html-italic">p</span> &lt; 0.0001, <b>****</b> <span class="html-italic">p</span> &lt; 0.00001 compared with IL-31- and-IL-33-stimulated group.</p>
Full article ">Figure 9 Cont.
<p><span class="html-italic">In vitro</span> effect of: (<b>A</b>) IL-6; (<b>B</b>) CCL2; and (<b>C</b>) CXCL8 release from IL-31- and IL-33-activated human eosinophils-dermal fibroblasts co-culture treated with berberine (Ber). Eosinophils (3 × 10<sup>5</sup>) and dermal fibroblast (8 × 10<sup>4</sup>) were pre-treated with or without Ber (5, 10, 25 and 50 µg/mL) and then cultured with or without human recombinant IL-31 and IL-33 (100 ng/mL) for further 18 h. Release of AD-related cytokine and chemokines in culture supernatants was determined by ELISA. Results are shown in bar charts with mean ± SEM (<span class="html-italic">n</span> = 5). <b>**</b> <span class="html-italic">p</span> &lt; 0.01, <b>***</b> <span class="html-italic">p</span> &lt; 0.0001, <b>****</b> <span class="html-italic">p</span> &lt; 0.00001 compared with IL-31- and-IL-33-stimulated group.</p>
Full article ">Figure 10
<p><span class="html-italic">In vitro</span> effect of: (<b>A</b>) CCL2; (<b>B</b>) CCL7; (<b>C</b>) CXCL8; (<b>D</b>) CCL22; and (<b>E</b>) TNF-α release from IL-31- and IL-33-activated human eosinophils treated with Gallic acid (GA). Eosinophils (3 × 10<sup>5</sup>) was pretreated with or without Gallic acid (10 and 50 µg/mL) and then cultured with or without human recombinant IL-31 and IL-33 (100 ng/mL) for further 18 h. Release of cytokines and chemokines in culture supernatants was determined by ELISA and Bio-plex pro assay. Results are shown in bar charts with mean ± SEM (<span class="html-italic">n</span> = 4).</p>
Full article ">Figure 10 Cont.
<p><span class="html-italic">In vitro</span> effect of: (<b>A</b>) CCL2; (<b>B</b>) CCL7; (<b>C</b>) CXCL8; (<b>D</b>) CCL22; and (<b>E</b>) TNF-α release from IL-31- and IL-33-activated human eosinophils treated with Gallic acid (GA). Eosinophils (3 × 10<sup>5</sup>) was pretreated with or without Gallic acid (10 and 50 µg/mL) and then cultured with or without human recombinant IL-31 and IL-33 (100 ng/mL) for further 18 h. Release of cytokines and chemokines in culture supernatants was determined by ELISA and Bio-plex pro assay. Results are shown in bar charts with mean ± SEM (<span class="html-italic">n</span> = 4).</p>
Full article ">Figure 11
<p><span class="html-italic">In vitro</span> effect of: (<b>A</b>) IL-6; (<b>B</b>) CCL7; (<b>C</b>) CCL22; and (<b>D</b>) TNF-α release from IL-31- and IL-33-activated human eosinophils-dermal fibroblast co-culture treated with Gallic acid (GA). Eosinophils (3 × 10<sup>5</sup>) and dermal fibroblasts (8 × 10<sup>4</sup>) were pretreated with or without GA (50 µg/mL) and then cultured with or without human recombinant IL-31 and IL-33 (100 ng/mL) for further 18 h. Release of cytokines and chemokines in culture supernatants was determined by ELISA and Bio-plex pro assay. Results are shown in bar charts with mean ± SEM (<span class="html-italic">n</span> = 3). <b>*</b> <span class="html-italic">p</span> &lt; 0.05, <b>**</b> <span class="html-italic">p</span> &lt; 0.01 when compared with the IL-31- and IL-33-stimulated group.</p>
Full article ">Figure 11 Cont.
<p><span class="html-italic">In vitro</span> effect of: (<b>A</b>) IL-6; (<b>B</b>) CCL7; (<b>C</b>) CCL22; and (<b>D</b>) TNF-α release from IL-31- and IL-33-activated human eosinophils-dermal fibroblast co-culture treated with Gallic acid (GA). Eosinophils (3 × 10<sup>5</sup>) and dermal fibroblasts (8 × 10<sup>4</sup>) were pretreated with or without GA (50 µg/mL) and then cultured with or without human recombinant IL-31 and IL-33 (100 ng/mL) for further 18 h. Release of cytokines and chemokines in culture supernatants was determined by ELISA and Bio-plex pro assay. Results are shown in bar charts with mean ± SEM (<span class="html-italic">n</span> = 3). <b>*</b> <span class="html-italic">p</span> &lt; 0.05, <b>**</b> <span class="html-italic">p</span> &lt; 0.01 when compared with the IL-31- and IL-33-stimulated group.</p>
Full article ">Figure 12
<p><span class="html-italic">In vitro</span> effect of CXCL8 release from IL-31- and IL-33-activated (<b>A</b>) eosinophils single alone and (<b>B</b>) eosinophils-dermal fibroblasts co-culture treated with chlorogenic acid (CGA). Eosinophils (3 × 10<sup>5</sup>) with or without co-culture with dermal fibroblast (8 × 10<sup>4</sup>) were pre-treated with or without CGA (5, 10, 20 and 40 µg/mL) and then cultured with or without human recombinant IL-31 and IL-33 (100 ng/mL) for further 18 h. Release of CXCL8 in culture supernatants was determined by ELISA. Results are shown in bar charts with mean ± SEM (<span class="html-italic">n</span> = 4). * <span class="html-italic">p</span> &lt; 0.05 when compared IL-31- and-IL-33-stimulated group.</p>
Full article ">
1443 KiB  
Communication
A Chemo-Enzymatic Road Map to the Synthesis of CoA Esters
by Dominik M. Peter, Bastian Vögeli, Niña Socorro Cortina and Tobias J. Erb
Molecules 2016, 21(4), 517; https://doi.org/10.3390/molecules21040517 - 20 Apr 2016
Cited by 54 | Viewed by 15488
Abstract
Coenzyme A (CoA) is a ubiquitous cofactor present in every known organism. The thioesters of CoA are core intermediates in many metabolic processes, such as the citric acid cycle, fatty acid biosynthesis and secondary metabolism, including polyketide biosynthesis. Synthesis of CoA-thioesters is [...] Read more.
Coenzyme A (CoA) is a ubiquitous cofactor present in every known organism. The thioesters of CoA are core intermediates in many metabolic processes, such as the citric acid cycle, fatty acid biosynthesis and secondary metabolism, including polyketide biosynthesis. Synthesis of CoA-thioesters is vital for the study of CoA-dependent enzymes and pathways, but also as standards for metabolomics studies. In this work we systematically tested five chemo-enzymatic methods for the synthesis of the three most abundant acyl-CoA thioester classes in biology; saturated acyl-CoAs, α,β-unsaturated acyl-CoAs (i.e., enoyl-CoA derivatives), and α-carboxylated acyl-CoAs (i.e., malonyl-CoA derivatives). Additionally we report on the substrate promiscuity of three newly described acyl-CoA dehydrogenases that allow the simple conversion of acyl-CoAs into enoyl-CoAs. With these five methods, we synthesized 26 different CoA-thioesters with a yield of 40% or higher. The CoA esters produced range from short- to long-chain, include branched and α,β-unsaturated representatives as well as other functional groups. Based on our results we provide a general guideline to the optimal synthesis method of a given CoA-thioester in respect to its functional group(s) and the commercial availability of the precursor molecule. The proposed synthetic routes can be performed in small scale and do not require special chemical equipment, making them convenient also for biological laboratories. Full article
(This article belongs to the Special Issue Biosynthesis of Natural Products)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Acyl-CoA thioesters that were successfully synthesized by one of the five different methods tested in this study. Color code: symmetric anhydride method, red; CDI-activation, green; ECF-activation, yellow; acyl-CoA-desaturation by AcDHs, blue; ATP dependent ligation by MatB, purple. Note that not all methods were tested with every substrate.</p>
Full article ">Figure 2
<p>Substrate promiscuity of the three acyl-CoA dehydrogenases characterized in this study. The following enzymes were cloned from <span class="html-italic">Rhodobacter sphaeroides</span> and produced heterologously in <span class="html-italic">Escherichia coli</span>: medium-chain acyl-CoA dehydrogenase, 424; putative short-chain acyl-CoA dehydrogenase, 423; putative branched-chain acyl-CoA dehydrogenase, 605. Conversion rates were measured by HPLC-UV at 260 nm as described in material and methods.</p>
Full article ">Figure 3
<p>Road map for the synthesis of biologically relevant CoA-thioesters. Shown in bold arrows are the five routes that have been established by our group (<b>Routes 1</b>–<b>4</b>, this study; <b>Route 5</b> [<a href="#B8-molecules-21-00517" class="html-bibr">8</a>]; <b>Route 6</b>, this study and [<a href="#B12-molecules-21-00517" class="html-bibr">12</a>,<a href="#B13-molecules-21-00517" class="html-bibr">13</a>]). These routes give access to all three classes of acyl-CoA esters with high yield and stereoselectivity. Alternative routes that are also discussed in the text are shown with dashed arrows. Abbreviations: AcDH, acyl-CoA dehydrogenases; ECR, enoyl-CoA reductases/carboxylases; MatB, methylmalonyl-CoA synthase. <sup>1</sup> Note that ECR (<b>Route 5</b>) produces the biologically relevant (<span class="html-italic">S</span>)-malonyl-CoA stereoisomers, whereas matB (<b>Route 6</b>) yields the (<span class="html-italic">R</span>)-stereoisomers and Meldrum’s acid (<b>Route 7</b>) derivatives a racemic mixture thereof.</p>
Full article ">
1152 KiB  
Article
Synthesis and Antitumor Evaluation of Novel 5-Hydrosulfonyl-1H-benzo[d]imidazol-2(3H)-one Derivatives
by Guang Ouyang, Rongsheng Tong, Jinqi Li, Lan Bai, Liang Ouyang, Xingmei Duan, Fengqiong Li, Pin He, Jianyou Shi and Yuxin He
Molecules 2016, 21(4), 516; https://doi.org/10.3390/molecules21040516 - 20 Apr 2016
Cited by 6 | Viewed by 5825
Abstract
A series of novel 5-hydrosulfonyl-1H-benzo[d]imidazol-2(3H)-one derivatives bearing natural product substructures has been successfully synthesized and their antitumor activity studied. These newly synthesized derivatives were characterized by 1H-NMR, 13C-NMR and high resolution mass spectral data, then [...] Read more.
A series of novel 5-hydrosulfonyl-1H-benzo[d]imidazol-2(3H)-one derivatives bearing natural product substructures has been successfully synthesized and their antitumor activity studied. These newly synthesized derivatives were characterized by 1H-NMR, 13C-NMR and high resolution mass spectral data, then screened as antitumor agents against the A549, HCC1937, and MDA-MB-468 human tumor cell lines using MTT cell proliferation assays. The results show that some of these compounds can effectively inhibit the growth of these cancerous cells, with compound 5b being the best one (IC50 = 2.6 μM). Flow cytometry data revealed that compound 5b induced apoptosis of HCC1937 cells with increased solution concentration. The structure and activity relationships (SAR) of these compounds is summarized. Full article
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Structures and activities of dibromophakellstatin 1A, halopemide 2A, isoform-selective PLD (PLD1 selective) inhibitors 3A and 4A, Pim 1/2 inhibitor 5-(5-((2-aminoethyl)amino)pyrazolo[1,5-<span class="html-italic">a</span>]pyrimidin-3-yl)-1<span class="html-italic">H</span>-benzo[d]imidazol-2(3<span class="html-italic">H</span>)-one, tubulin inhibitor E7010.</p>
Full article ">Figure 2
<p>Flow cytometry results.</p>
Full article ">Figure 3
<p>Molecular docking of <b>5b</b> and CDK2.</p>
Full article ">Scheme 1
<p>Syntheses of compounds <b>5a</b>–<b>o</b>. <span class="html-italic">Reactions and conditions</span>: (<b>a</b>) NaOH, benzyl bromide or (2-bromoethyl)benzene, acetone, 65 °C, 1.5 h; (<b>b</b>) chlorosulfonic acid, 0 °C, 4 h; (<b>c</b>) ammonia derivatives, THF, rt, 0.5 h; (<b>d</b>) Fe/HCl, silica gel, 80% ethyl alcohol, 80 °C, 1 h; (<b>e</b>) triphosgene, anhydrous THF, 0 °C, 0.5 h.</p>
Full article ">
916 KiB  
Article
Evaluation of Olive Fruit Lipoxygenase Extraction Protocols on 9- and 13-Z,E-HPODE Formation
by Barbara Soldo, Matilda Šprung, Gloria Mušac, Maja Pavela-Vrančić and Ivica Ljubenkov
Molecules 2016, 21(4), 506; https://doi.org/10.3390/molecules21040506 - 20 Apr 2016
Cited by 3 | Viewed by 4871
Abstract
In plant tissues, enzymes implicated in the lipoxygenase (LOX) pathway are responsible for the hydroperoxydation of polyunsaturated fatty acids, ultimately leading to the production of small chemical species involved in several physiological processes. During industrial olive oil production, these enzymes are activated upon [...] Read more.
In plant tissues, enzymes implicated in the lipoxygenase (LOX) pathway are responsible for the hydroperoxydation of polyunsaturated fatty acids, ultimately leading to the production of small chemical species involved in several physiological processes. During industrial olive oil production, these enzymes are activated upon crushing and grinding of olive fruit tissue, subsequently leading to the synthesis of volatile compounds responsible for the positive aroma and flavor of the oil. An investigation of LOX activity during olive fruit ripening and malaxation could assist in the production of oils with favorable aroma and taste. Therefore, a reliable method for olive LOX purification is crucial. Here we report a critical review of six LOX extraction protocols, two of which have shown minimum enzyme activity, possibly leading to misconceptions in the interpretation of experimental data. Future research concerning olive LOX should employ extraction methods that preserve enzyme activity. Full article
(This article belongs to the Section Natural Products Chemistry)
Show Figures

Figure 1

Figure 1
<p>Lipoxygenase (LOX) activity calculated from the amount of: (<b>A</b>) 9-<span class="html-italic">Z</span>,<span class="html-italic">E</span>-HPODE and (<b>B</b>) 13-<span class="html-italic">Z</span>,<span class="html-italic">E</span>-HPODE, as determined by RP-HPLC with depicted bars representing * <span class="html-italic">p</span> &lt;&lt; 0.05 (Anova, single factor and Scheffe test).</p>
Full article ">Figure 2
<p>Overlaid representation of chromatograms of LOX product formation obtained by applying protocol 1, 3 and 5.</p>
Full article ">
4072 KiB  
Article
The Apoptotic Effect of Ursolic Acid on SK-Hep-1 Cells is Regulated by the PI3K/Akt, p38 and JNK MAPK Signaling Pathways
by Wan-Ling Chuang, Ping-Yi Lin, Hui-Chuan Lin and Yao-Li Chen
Molecules 2016, 21(4), 460; https://doi.org/10.3390/molecules21040460 - 20 Apr 2016
Cited by 32 | Viewed by 6308
Abstract
Ursolic acid (UA) is a pentacyclic triterpene acid that is present in a wide variety of medicinal herbs and edible plants. This study investigated the effect of UA on apoptosis and proliferation of hepatocellular carcinoma SK-Hep-1 cells. After treatment of SK-Hep-1 cells with [...] Read more.
Ursolic acid (UA) is a pentacyclic triterpene acid that is present in a wide variety of medicinal herbs and edible plants. This study investigated the effect of UA on apoptosis and proliferation of hepatocellular carcinoma SK-Hep-1 cells. After treatment of SK-Hep-1 cells with different concentrations of UA, we observed that cell viability was reduced in a dose- and time-dependent manner. Furthermore, there was a dose-dependent increase in the percentage of cells in the sub-G1 and G2/M phases, with cells treated with 60 μM showing the highest percentages of cells in those phases. UA-induced chromatin condensation of nuclei was observed by using DAPI staining. The western blot results revealed that exposure to UA was associated with decreased expression of the anti-apoptotic proteins Mcl-1, Bcl-xL, Bcl-2, and TCTP and increased expression of apoptosis-related proteins TNF-α, Fas, FADD, Bax, cleaved caspase-3, caspase-8, caspase-9, and PARP. Immunocytochemistry staining showed that treatment with UA resulted in increased expression of caspase-3. Moreover, exposure to UA resulted in the inhibition of the PI3K/Akt and p38 MAPK signaling pathways. These findings suggest that UA inhibits the proliferation of SK-Hep-1 cells and induces apoptosis. Full article
(This article belongs to the Section Natural Products Chemistry)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>The structure of UA (3β-hydroxyurs-12-en-28-oic acid).</p>
Full article ">Figure 2
<p>SK-Hep-1 cells (2 × 10<sup>4</sup> cells/well) were treated with various concentrations of UA (0, 10, 20, 30, 40, 50, and 60 μM) for 24, 48, or 72 h. Cell viability was measured using the MTT assay. The cytotoxicity of UA in SK-Hep-1 cells was dose-dependent. Each point is the mean ± SD of three experiments. * indicates significant difference from control, <span class="html-italic">p</span> &lt; 0.001.</p>
Full article ">Figure 3
<p>Effect of UA on the cell cycle of SK-Hep1 cells. (<b>a</b>) SK-Hep1 cells were treated with 0, 20, 40, and 60 μM UA for 24 h, after which the cells were stained with PI and analyzed by FACS; (<b>b</b>) Quantitative results of cell cycle percentages. FACS, fluorescence-activated cell sorting.</p>
Full article ">Figure 4
<p>DAPI staining showing the effect of UA on chromatin condensation in SK-Hep-1 cells after treatment with 0, 20, 40, and 60 μM UA for 24 h. Images were obtained with an Olympus IX81 microscope.</p>
Full article ">Figure 5
<p>Immunocytochemical analysis. SK-Hep-1 cells were treated with 0, 20, 40, and 60 μM UA for 24 h and then fixed with 4% paraformaldehyde to allow for detection by caspase 3 antibody. The results revealed that treatment with UA for 24 h resulted in increased expression of caspase-3.</p>
Full article ">Figure 6
<p>The effects of UA on protein expression of TNF-α, Fas, FADD, Mcl-1, Bax, TCTP, Bcl-2, and PARP in SK-Hep-1 cells. SK-Hep-1 cells were treated with UA (0, 20, 40, and 60 μM) for 24 h and protein expression was evaluated by western blotting. The results showed that UA resulted in increased protein expression of (<b>a</b>) TNF-α, Fas and FADD; (<b>b</b>) decreased expression of Mcl-1, TCTP, and Bcl-2, and increased protein expression of Bax and Bcl-xL. β-Actin served as a loading control.</p>
Full article ">Figure 7
<p>Activation of caspase-3, caspase-8, caspase-9, and PARP protein expression in SK-Hep-1. SK-Hep-1 cells were treated with UA (0, 20, 40, and 60 μM) for 24 h and the protein expression was evaluated by western blotting. The results showed that UA treatment resulted in increased protein expression of cleaved caspase-3, cleaved caspase-8, cleaved caspase-9, and cleaved PARP. β-Actin served as a loading control.</p>
Full article ">Figure 8
<p>Effects of UA on the MAPK pathway and the PI3K/Akt pathway in SK-Hep-1 cells. The cells were treated with various concentrations of UA (0, 20, 40, and 60 μM) for 24 h. The levels of phosphorylation of PI3K, Akt, ERK1/2, JNK1/2, and p38 were detected by western blot analysis. β-Actin served as a loading control.</p>
Full article ">
2293 KiB  
Article
Phenolic and Chromatic Properties of Beibinghong Red Ice Wine during and after Vinification
by Jin-Chen Li, Si-Yu Li, Fei He, Zheng-Yi Yuan, Tao Liu, Malcolm J. Reeves and Chang-Qing Duan
Molecules 2016, 21(4), 431; https://doi.org/10.3390/molecules21040431 - 20 Apr 2016
Cited by 14 | Viewed by 6201
Abstract
The phenolic and chromatic characteristics of a special red ice wine made from a Vitis amurensis × V. vinifera hybrid cultivar Beibinghong were studied. Results from two different vintages (2013 and 2014) showed that during vinification, the phenolic acid content increased, while the [...] Read more.
The phenolic and chromatic characteristics of a special red ice wine made from a Vitis amurensis × V. vinifera hybrid cultivar Beibinghong were studied. Results from two different vintages (2013 and 2014) showed that during vinification, the phenolic acid content increased, while the level of flavonoids (flavonols, flavan-3-ols, and anthocyanins) reduced by a variable extent. The color intensity and red % decreased together with a decrease in anthocyanin content. This was accompanied by an increase in hue as well as yellow %. The final phenolic content was found to be between 119.54 and 180.93 mg/L, with anthocyanins as the predominant phenolic group (92.06%–93.03%), of which 3,5-O-diglucosidic anthocyanins made up 53.55%–79.04%. Phenolic acids were the primary non-anthocyanin phenolics at about 6.64%–7.5%. The phenolic contents and color parameters of Beibinghong dry red wine and several V. vinifera dry red wines of superior color quality were also used in an attempt to clarify the relationship between phenolics and color in the Beibinghong red ice wine. By using Pearson correlation analysis and principal component analysis (PCA), it was found that 3,5-O-diglucosidic anthocyanins and protocatechuic acid were the only characteristic phenolics that differentiated Beibinghong wines from the other selected red wines from more traditional varieties. They were also the main phenolics to be positively correlated with the hue and yellow % of the wine at the early stages leading into maturation. Their presence might, therefore, explain the relatively high hue and yellow % of Beibinghong ice wine. Full article
(This article belongs to the Collection Wine Chemistry)
Show Figures

Figure 1

Figure 1
<p>The family tree of hybrid cultivar Beibinghong.</p>
Full article ">Figure 2
<p>Phenolic evolution during vinification of Beibinghong red ice wine from two vintages, 2013 and 2014. (<b>a</b>) Evolution of anthocyanins during vinification; (<b>b</b>) Evolution of hydroxybenzoic acids during vinification; (<b>c</b>) Evolution of hydroxycinnamic acids during vinification; (<b>d</b>) Evolution of flavan-3-ols during vinification; (<b>e</b>) Evolution of flavonols during vinification.</p>
Full article ">Figure 3
<p>Chromatic evolution during vinification of Beibinghong red icewine from two vintages, 2013 and 2014. (<b>a</b>) Evolution of color intensity during vinification; (<b>b</b>) Evolution of red % during vinification; (<b>c</b>) Evolution of hue during vinification; (<b>d</b>) Evolution of yellow % during vinification.</p>
Full article ">Figure 4
<p>Pearson correlation analysis between phenolic compounds and color parameters.</p>
Full article ">Figure 5
<p>Correlation coefficients of color parameters with phenolic compounds.</p>
Full article ">Figure 6
<p>PCA analysis of phenolic compounds in different wine products.</p>
Full article ">Figure 7
<p>Loading plots of different phenolic compounds in PC1 and PC2.</p>
Full article ">
Previous Issue
Next Issue
Back to TopTop